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A model of acute glutamate- and domoate-induced toxicity was developed and 
characterized in cultured rat cerebellar granule cells (CGCs) using experimental 
conditions which preserve the voltage-dependency of NMDA receptor function. 
Glutamate, which is normally non-toxic to CGCs in physiologic media (pH 7.4), 
was shown to induce a cytotoxic response after 2 hours when the exposure 
temperature was reduced from 37° to 22°. Pharmacological characterization of 
this response demonstrated that cytotoxicity is mediated by the activation of 
NMDA receptors, while non-NMDA receptors produce a depolarizing stimulus 
that enhances release of the voltage-dependent Mg2+ blockade of NMDA receptor 
ion channels. Reduced temperature was shown to facilitate NMDA receptor 
activation  by compromising  the  ability  of CGCs  to  maintain  normal 
electrochemical gradients during glutamate-induced ion flux. When compared  to 
glutamate, the non-NMDA receptor agonist, domoate, demonstrated  an acute 
cytotoxic response in CGCs that was also mediated predominantly by NMDA 
receptors. NMDA receptor activation was produced secondary to a domoate­
induced release of glutamate and aspartate from CGCs; therefore, domoate 
synergistically potentiates glutamate/aspartate-mediated neurotoxicity.  Domoate­
Redacted for Privacyinduced excitatory amino acid (EAA) release was investigated and found to occur 
almost exclusively through reversal of the high affinity Na+-coupled glutamate 
transporter and by osmoregulatory mechanisms. CGCs also responded to 
domoate-induced  depolarization  by  releasing  adenosine  which  suppresses 
exocytotic EAA release through A 1 receptor activation. 
The functional and pharmacological characteristics of NMDA receptors 
were characterized in 12 DIC CGCs using the channel blocking compound 
[3H]MK -801 (dizocilpine). Kinetic analysis of [3H]MK -801 binding indicated the 
possible existence of at least two NMDA receptor populations on 12 DIC CGC 
membranes, and the equilibrium competition binding of MK-801 and other 
channel blocking compounds was consistent with the presence of high and low 
affinity binding sites. The neuroprotective potencies of NMDA receptor channel 
blockers correlated significantly with their affinities for the NMDA receptor 
derived from equilibrium competition analysis of [3H]MK -801  high-affinity 
binding. Thus, whereas 12 DIC CGCs express a pharmacologically heterogeneous 
population  of NMDA receptors,  it  is  the  high-affinity  component  of 
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L-glutamate is the primary excitatory neurotransmitter in the mammalian central 
nervous system (CNS). It excites virtually all central neurons and is present within 
neuronal synapses at millimolar concentrations (1). In addition to its involvement in rapid 
excitatory neurotransmission, glutamate plays a central role in synaptic plasticity,  an 
activity-dependent process involved in synapse formation and memory aquisition (2,3), 
and in the neurodegeneration associated with a variety of acute and chronic neurological 
disorders (4). The neurotoxic potential of glutamate was first demonstrated in 1957 by 
Lucas and Newhouse (5), who showed that retinal neurons degenerate after prolonged 
periods of glutamate exposure. Subsequent experiments by Olney (6,7)  established that 
this toxicity not only applied to glutamate (and retinal neurons), but  was an effect 
common to the actions of a variety of excitatory amino acids on central  neurons. This 
effect, which Olney called excitotoxicity, was postulated to be the cause of neuronal loss 
that occurs in a variety of neurological diseases (6). Indeed, with the ongoing elucidation 
of glutamate receptor structure and function, the development of a large pharmacopoeia 
of glutamate receptor agonist and antagonist drugs, and the establishment of numerous in 
vivo and in vitro experimental systems: this hypothesis has  gained strong support (4). 
Moreover, the evidence increasingly suggests that glutamate neurotoxicity is involved in 
slowly progressive neurodegenerative diseases such  as Huntington's, Alzheimer's and 
ALS (8). 1 
Because glutamate has been implicated  in  a number of important CNS 
pathologies, the mechanisms by which it produces neurotoxicity have been extensively 
studied. Less well characterized, however, are the mechanisms associated with the 
toxicity of a variety of exogenous excitatory amino acids. One such toxin of recent 
importance to human health is domoic acid, a tricarboxylic amino acid produced by the 
red seaweed Chondria armata that is well known in the Japanese pharmacopoeia for its 
anthelmintic properties (9) (figure 1.1). In November/December, 1987. domoate was the 
agent responsible for an unusual intoxication, called amnesic shellfish poisoning (ASP). 
among people who had eaten mussels (Mitilus edulis) grown commercially off Prince 
Edward Island in Eastern Canada (10,11). In this outbreak, however, domoic acid was 
found to have been synthesized by the pennate diatom, Nitzschia pungens (12). The 
neurological symptoms of ASP included headache, confusion, nausea, disorientation, 
seizures, loss of memory, coma and death, with the most serious problems occurring in 
older patients (10). Autopsy of the brains from four people who died due to domoate 
toxicity revealed neuronal damage in the amygdala, hippocampus and other limbic areas 
(11)  in  a pattern  similar  to  that observed experimentally  in  animals  after  the 
administration of the structurally related analog, kainic acid (figure 1.1) (13,14). Since its 
first documented appearance in seafood in 1987, domoate has continued to  appear not 
only in cultured mussels, but in other filter feeding species such as clams, crabs and 
anchovies on both the east and west coasts of the US and Canada (15,16). Moreover,  a 
number of other species of unicellular algae which synthesize domoate have been 
identified in recent seafood contaminations (17,18). 
In this thesis project, cultured rat cerebellar granule neurons were used  as an in 
vitro model to study cellular mechanisms involved in domoate- and glutamate-mediated 
neurotoxicity. Given the increasing occurrence of domoic acid contamination in shellfish, 
knowledge of the cellular and biochemical pathways involved in domoate excitotoxicity 
would be extremely important to the development of therapeutic strategies  for future human intoxications. Moreover, excitatory amino acids such as domoate may be useful 
tools for the modeling of siezure disorders, inasmuch as the glutamate receptor subtypes 
with which domoate interacts play an important role  in epilepsy (19,20). Most 
importantly perhaps, an understanding of domoate excitotoxic mechanisms may broaden 
our understanding of the many neurological diseases thought to involve abnormal 
glutamate receptor function. The following sections will review glutamate receptor 
structure and function,  the important cellular components involved in  glutamate 
excitotoxicity, and the considerations in selecting cultured cerebellar granule neurons to 
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Fig. 1.1 Chemical structure of glutamate, domoate and kainate 4 
1.1 Glutamate Receptors 
Glutamate interacts with two major receptor families: ionotropic, ligand gated ion 
channels and metabotropic G-protein coupled receptors (21). Ionotropic glutamate 
receptors have been classified pharmacologically into N-methyl-D-aspartate (NMDA) and 
non-NMDA receptors, with the latter being further differentiated pharmacologically into 
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) and kainate  preferring 
subtypes  (AMPA/kainate  receptors)  (21-23).  Physiologically,  rapid  glutamatergic 
neurotransmission is mediated by non-NMDA receptors. which in general are selectively 
permeable to Na+ and K+ (24,25). NMDA receptors form Na- and Ca2+-permeable ion 
channels that are activated in both a voltage and ligand dependent manner (21.26,27). 
Because NMDA receptors are blocked by Mg2+ in a voltage dependent manner, calcium 
influx increases in response to increasing levels of membrane depolarization such as that 
which occurs during high frequency synaptic activity. In this context, calcium activates 
processes that  are fundamental to long term changes in  synaptic  strength  (2.3). 
Metabotropic glutamate receptors are coupled to the activation of phospholipase C (PLC) 
and release of Ca2 from intracellular stores, and to inhibition of adenylyl cyclase (28,29). 
Thus, metabotropic glutamate receptors can produce both prolonged excitatory and 
inhibitory effects in the CNS and are involved in numerous neuronal functions including 
synaptic plasticity and neuronal development (29, 30). 
1.1.1  Ionotropic Glutamate Receptors 
All ionotropic glutamate receptors exist as oligomeric proteins comprised of 
several  subunits which coassemble  to form functional  cation  channels  (21-25). 
Glycosylation analysis and electrophysiological testing of mutant and chimeric receptors 
indicate that each subunit contains multiple membrane spanning domains (31-34). 5 
General features of ionotropic glutamate receptor subunit structure include: (i) a large 
extracellular N-terminal domain comprising approximately one-half of the subunit 
(21,36-41); (ii) three membrane spanning domains (TM1, TM3 and TM4)(31 -35): (iii) a 
fourth channel-lining reentrant loop (TM2) that enters and exits the cell membrane from 
the intracellular side (31-35); and (iv) an intracellular C-terminal domain (31-35, 42-44). 
Other general features include: a Q/R/N site in TM2 which governs the ion permeability 
characteristics of all ionotropic glutamate receptors (23,24,45-51); amino acid sequences 
in the extracellular loop segment between TM3 and TM4 and in the N-terminus that share 
sequence homology with bacterial periplasmic amino acid-binding proteins and which 
together form the glutamate binding domain of the receptor (33.52); and intracellular 
phosphorylation consensus sequences (44.57-61). 
Non-NMDA receptors. Non-NMDA receptor subunits are encoded by nine 
different genes, and have been subclassified into three groups based on their sequence 
similarity and agonist selectivity (23,24). Sequence homology of subunits within each 
group generally exceeds 80 %, whereas inter-group similarity is low (40 %) (39.70). 
Thus. GluR1 through G1uR4 subunits comprise the AMPA-preferring receptors (62). 
AMPA receptor subunits have been shown to assemble into functional homomeric  or 
heteromeric oligomers with different functional properties (21-24,46,62,63). GluR5 
through G1uR7 and KA- I/KA-2 subunits constitute low and high affinity kainate 
receptors, respectively (64-71). KA-1 and KA-2 subunits by themselves do not form 
functional receptors, but instead combine with G1uR5-7 to form high affinity kainate 
receptors (70,71). Evidence from in vitro studies indicates that both homooligomeric 
G1uR5-G1uR7 and heteromeric G1uR5-6/KA1-2 channels may exist in vivo, whereas 
kainate and AMPA subunits do not heterooligomerize (68,70,72,73)  . 
Non-NMDA receptors display considerable diversity in activation and channel 
gating characteristics, due largely to the variety of possible receptor subunit combinations 6 
that exist within the CNS: however, a greater level of molecular and functional diversity 
is created through non-NMDA receptor subunit pre-mRNA editing mechanisms (51). An 
early discovery was that the genomic sequences of all non-NMDA receptors encode for 
glutamine (Q) at the Q/R/N site of TM2, whereas arginine (R) is found in virtually all 
GluR2, and at varying developmentally controlled ratios in GluR5 and GluR6 subunit 
cDNAs (25,74-76). It is now known that pre-mRNA editing of glutamine codons (CAG) 
to arginine (CGG) codons occurs by a process of adenosine deamination in G1uR2, 
GluR5 and G1uR6 subunits (51,77). In general, it  is the presence of this positively 
charged arginine residue in the channel lining domain that determines the selective 
permeability of non-NMDA receptors for monovalent cations (74). The absence of 
arginine renders non-NMDA receptors permeable to both mono- and di-valent cations. 
Thus, although non-NMDA receptors had originally been thought to selectively conduct 
monovalent cations, it has now been shown that glutamate can trigger Ca2±-dependent 
intracellular events directly through Ca2+-permeable AMPA/kainate receptors in  some 
neuronal and glial cells (78,79). Because of the wide distribution of edited subunits, 
however, the vast majority of CNS neurons contain Na+/K+ permeable AMPA and 
kainate receptors (74). 
The molecular complexity of AMPA receptors is increased further by alternative 
splicing of a functional module of 38 amino acids in one of two sequence versions, 
termed flip and flop (80), located in the extracellular loop between TM3 and TM4. 
Coupled with this feature is the presence of an R/G site in GluR2, G1uR3 and GluR4, 
which directly precedes the flip/flop module, and is edited in similar fashion to the Q/R/N 
site of TM2 (81). Both of these post-transcriptional processing features  appear to be 
active during CNS development for the fine tuning of the kinetic properties of AMPA 
receptors. Flip versions of AMPA receptor subunits with unedited R/G sites (R is present) 
are  generally more numerous at  earlier developmental stages  (81).  Functionally, 
homooligomeric AMPA receptors containing the flip module have been  shown to 7 
desensitize more slowly than flop-containing receptors (82). Moreover, the timecourse of 
recovery from desensitization is affected by R/G site editing such that R-containing 
AMPA receptors recover more rapidly. Thus, developmentally interrelated flip/flop 
splicing (83) and R/G site editing (81) affect the size and shape of the fast component of 
excitatory post-synaptic currents and control the ability of neurons to convey rapid trains 
of synaptic activity. 
Among the kainate-preferring non-NMDA receptors, the GIuR6 subunit displays 
additional unique sites for pre-mRNA editing. Two sites, both located in transmembrane 
segment TM1, are diversified by RNA editing to generate either isoleucine (I) or valine 
(V) in one and tyrosine (Y) or cysteine (C) in the other TM1 position (23,50). In contrast 
to AMPA receptor channels, the presence of Q in the TM2 Q/R/N site of GIuR6 results in 
channels with low Ca  permeability, whereas an R residue produces a higher Ca 
2+ 
permeability if the IN and Y/C sites of TM I are fully edited (V and C residues present). 
If the TM1 sites are unedited, Ca2+ permeability is less dependent on the  presence of 
either Q or R in TM2 (23,50). Thus the Ca2+ permeability of kainate receptor channels 
can vary depending upon editing within both the TM I and TM2 domains. Moreover, the 
pairing of RNA editing with specific heteromeric subunit assemblies might be used to 
regulate and diversify Ca
2+  permeability properties, since combinations of edited and 
unedited subunits expressed in  vitro appear to  create  a wide spectrum of Ca2+ 
permeabilities among kainate receptors (23,50). 
Finally, alternatively spliced C-terminal sequences have been found in GluR2 and 
G1uR4 subunits (84,85). These long and short molecular forms have been demonstrated in 
murine brain, however their functional and developmental significance have not yet been 
studied. 
NMDA receptors. NMDA receptors are composed of two distinct  types of 
subunits that are encoded by five separate genes; one type is termed NMDAR 1 (NR I) and 8 
the other type is comprised of four subunits termed NMDAR2A to NMDAR2D (NR2A­
D) (21,2124). The mouse homologues have been designated  and £ for NR1 and NR2. 
respectively (36,39). NR1 is capable of assembling as a homooligomer that displays 
properties characteristic of native NMDA receptors when expressed in Xenopus oocytes 
(21,36). NR2 subunits, however, do not form functional receptors but instead potentiate 
NMDA receptor-gated currents and confer specific functional properties to NMDA 
receptors when in heteromeric assembly with NR1. (41,86). Because NR1 subunits are 
required for the formation of functional NMDA receptors, they are expressed in virtually 
all  neurons of the CNS, whereas NR2 subunits  display  distinct  regional  and 
developmentally regulated expression patterns (38,87). Recent data suggest that NMDA 
receptors contain at least two different NR2 subunit types in combination with NR1 
(88,89). Thus, a large variety of possible NR1/NR2 subunit combinations would account 
for the regionally heterogenous functional and pharmacologic diversity of NMDA 
receptors in the CNS (90-93). 
The functional and molecular diversity of NMDA receptors is enhanced even 
further, in a fashion similar to non-NMDA glutamate receptors, by post-transcriptional 
RNA editing of the NR1 subunit. Differential splicing of three different exons generates 
eight  possible  isoforms,  seven  of  which  have  been  identified  in  vivo 
(21.40,43,86.94,103). Each isoform is expressed in a regionally and developmentally 
characteristic fashion (86). One alternatively spliced exon casette, located in the N-
terminal extracellular domain (NI), encodes a 21 amino acid sequence. while adjacent 37 
and 38 amino acid sequences (C1 and C2) exist in the C-terminus domain. Splicing out 
the distal C-terminal cassette removes a stop codon, which exposes a new open reading 
frame that encodes 22 amino acids (C2') before a second stop codon is encountered (43). 
Thus, NR1 subunit splice variants differ in two regions: the distal end of the amino-
terminus domain with two configurations;  and  the  carboxy-terminus  with  four 
configurations. 9 
The NMDA receptor-channel complex is distinct among glutamate receptors in 
that it is highly permeable to Ca2+ and blocked in a voltage-dependent manner by Mg2+ 
(21,26,27). These properties underlie the ability of NMDA receptors to mediate the 
induction of long-term potentiation of synaptic efficacy, a form of activity-dependent 
synaptic plasticity that underlies learning, memory and CNS development (2,3). The 
property of Ca2+ permeability is conferred to the NMDA receptor-channel complex by an 
asparagine (N) residue at the TM2 Q/R/N site, which is present in all NMDA receptor 
subunits (48,49,74). Mutations at the site of the conserved asparagine residue reduce or 
abolish Ca2+-permeability and have been shown to alter the sensitivity to channel 
blockade by Mg2+ and the prototypical channel blocking drug MK-801 (48,49,74). 
In addition to the fundamental properties of Ca2+ permeability and voltage-
dependent Mg2+ blockade, NMDA receptors are modulated by a variety of endogenous 
and exogenous inhibitory and potentiating agents. The presence of glycine, which binds 
to a distinct strychnine-insensitive coagonist site, is required for glutamate to activate 
NMDA receptors (95-98). The glycine binding site has been shown to exist within an 
extracellular domain that shares sequence similarity with a periplasmic amino acid-
binding  protein  from  Salmonella  typhimurium  (33,52).  Glutamate  and  glycine 
reciprocally enhance one another's affinity for binding to the NMDA receptor (99). 
NMDA receptors also possess a pharmacologically distinct modulatory site for the 
binding of Zn2+ (94,100). Zn2+ at high concentrations inhibits agonist-induced responses, 
whereas at low concentrations it potentiates responses at certain splice variants of the 
NMDA receptor (94). The Zn2+-induced potentiating responses appear to  occur without 
increasing NMDA receptor agonist or glycine potency and are mimicked by several heavy 
metal cations (94). As many as three sites exist on NMDA receptors for the binding of 
polyamines (94,99,100). Polyamines exert multiple effects on the NMDA receptor, which 
include an increase in the magnitude of agonist-induced currents in the presence of 
saturating concentrations of glycine, an increase in the affinity of the receptor for glycine, 10 
and voltage-dependent inhibition (101). These effects vary depending on the specific 
subunit composition of the NMDA receptor. Several extracellular redox-sensitive amino 
acid residues modulate receptor activation properties (53-56). Overlapping the polyamine 
sites within the lumen of the cation channel are sites for non-competitive NMDA receptor 
antagonist drugs such as phencyclidine (PCP), which block NMDA-induced currents in a 
voltage- and use-dependent manner (49,90-93). 
Electrophysiological experiments on recombinantly expressed NMDA receptors 
indicate that each of the NR1 splice variants is capable of assembling into functional 
homomeric channels (36,40,41,44,57,59.94,102), and each variant differs with respect to 
agonist affinity, current amplitude, modulation by Zn 
2+,  potentiation by polyamines and 
regulation by PKC. For example, NR1 homomers containing  the N1  cassette 
(NR lixx)i generally produce larger mean current amplitudes but have a lower affinity for 
glutamate than do receptors without the Ni cassette (40,102). Moreover, Zn2+ and 
spermine potentiate responses at NR10xx but not NR 11 xx homomers (40,94.102) The 
potentiating effect of PKC phosphorylation appears to be modulated by both the N- and 
C-terminal cassettes (57.59). Interestingly, PKC phosphorylation has been shown to occur 
predominantly on serine residues located entirely within the C 1 cassette, which suggests 
that sensitivity of the NMDA receptor to phosphorylation can be regulated through 
alternative splicing of the C-terminal domain (44). 
Various binary combinations of NR1 and NR2 subunits have been recombinantly 
expressed and investigated for their functional properties as well. In general, many of the 
functional and pharmacologic characteristics of native NMDA receptors  are reproduced 
by these combinations. For example, NMDA-activated currents in Xenopus  oocytes 
'At this time,  a unified nomenclature for the various NR1 isoforms has not been 
established. The eight splice variants have been denoted by Durand, et al. (1993) with 
subscripts which indicate the presence (1) or absence (0) of the three alternatively spliced 
exons from the 5' to 3' end. Thus. NR 1011 designates a subunit that lacks the Ni but has 
both Cl and C2 cassettes. An 'x' indicates that the presence of an exon is indeterminate. expressing NR1 and NR2B or NRI and NR2C subunits have been demonstrated to be 2 
to 25 times smaller than those produced by recombinantly expressed NR I-NR2A subunits 
(38,39), and the affect of Mg2+ to block inward currents is weaker in NR1-NR2C and 
NRI-NR2D as compared to NR1-NR2A and NRI-NR2B heteromers (103). Moreover, 
the rate of current decay is 3 to 30 times more rapid for NR1-NR2A receptors than for 
any of the other heteromeric subunit combinations (38.103). Regarding ligand affinities. 
NR1-NR2A and NR1-NR2B recombinants display a higher affinity for glutamate than 
NR1-NR2C recombinants, whereas the latter displays up to ten-fold higher glycine 
affinity (104). A similar profile exists for the channel blocking compound, MK-801, in 
which the affinity at NR1-NR2A and NR1-NR2B receptors has been demonstrated to be 
as much as thirty times higher than for NR1-NR2C recombinants (88.89.104). Thus, 
recombinant NMDA receptors reproduce many of the functional characteristics of native 
NMDA receptors found in brain regions where these subunits have been detected. 
1.1.2 Metabotropic glutamate receptors 
To date, eight different metabotropic glutamate receptors (mGluR 1-8) have been 
identified and numbered according to the order in which their cDNA's were cloned (28). 
mGluRs have been classified into 3 groups with approximately 70% intra-group and 45% 
inter-group sequence identity (21.28). Group I receptors, comprised of mGluR 1  and 
mGluR 5, are coupled through PLC to the hydrolysis of inositol phospholipids, yielding 
inositol triphosphate (IP3) and diacylglycerol (DAG). Thus Group I  metabotropic 
glutamate receptors mobilize intracellular Ca- and stimulate protein kinase C activity 
(21,28,105). Group II (mGluR 2-3) and III (mGluR 4,6-8) metabotropic glutamate 
receptors are negatively coupled to adenylate cyclase through inhibitory G-proteins 
(28,105). Interestingly, although mGluRs couple to the same G-proteins as other members 
of the G-protein coupled receptor superfamily, they do not share sequence similarity with 12 
other G-protein coupled receptors (106). Instead, mGluRs appear to be more closely 
related to a Ca2+-sensing receptor recently isolated from bovine parathyroid gland (107). 
Metabotropic glutamate receptors therefore define a new family of G-protein coupled 
receptors. 
1.2  Mechanisms of Neuronal Excitotoxicity 
1.2.1  Glutamate Toxicity 
Of all excitatory amino acids (EAAs) known to produce toxic effects in the central 
nervous  system,  the  neurotransmitter  glutamate  has been  the  most extensively 
characterized because of its involvement in CNS pathologies associated with hypoxia, 
ischemia, trauma, hypoglycemia and epilepsy (4). As previously described, rapid 
glutamatergic neurotransmission is mediated by non-NMDA receptors (AMPA/kainate 
receptors) (1-3), whereas NMDA receptors serve as coincident detectors requiring 
concurrent depolarizing stimuli, such as that which occurs during high frequency synaptic 
activity, to relieve the voltage-dependent Mg2+ blockade of the ion channel (21,24). In 
this physiologic context, NMDA receptors increase cytoplasmic Ca2+ concentrations at 
discreet, active synapses, and thereby activate processes fundamental to long term 
changes in synaptic strength (2,3). In certain pathological conditions, however, excessive 
glutamate receptor stimulation induces large and sustained NMDA receptor-mediated 
increases in cytoplasmic Ca2+ concentration that ultimately cause neuronal death (108­
110 ). 
Normally, extracellular glutamate concentrations rise to high levels only briefly, 
and in a spatially localized manner. This occurs because glutamate is rapidly removed 
from the extracellular space by a high affinity Na+-coupled glutamate transporter, which 
is present in both neurons and glia (111-114). Three Na+ are co-transported inward with 13 
each glutamate molecule against one outwardly transported K+ for a net influx of one 
positive charge (114). Thus, the glutamate transporter is indirectly driven by Na+/K+ 
ATPase, which utilizes approximately 60% of available cellular ATP to maintain 
neuronal transmembrane electrochemical gradients (115). The efficiency of glutamate 
reuptake is high enough that extremely large doses of intracerebrally injected glutamate 
are required to induce CNS lesions (116). During acute CNS pathologies, however, 
disruptions in oxygen or glucose availability deprive neurons and glia of the energy 
required to sustain normal Na+/K+ ATPase activity (117-119). The resultant neuronal 
depolarization increases synaptic glutamate release and impairs or even induces a 
reversed mode of glutamate transporter function, with the consequence that neurons incur 
prolonged exposures to high concentrations of extracellular glutamate. (120-123). 
In neurotoxicological experiments utilizing dissociated hippocampal and cerebral 
cortical neuronal cultures, brief exposures to elevated glutamate concentrations have been 
shown to produce two distinct phases of neuronal injury (4.124). An early phase, 
mediated by the depolarization-dependent influx of Na+,  and water, manifests as a 
rapidly developing neuronal swelling that is reversible if either glutamate concentration 
or exposure duration are limited (125,126). This early component has been linked to the 
activation of AMPA/kainate receptors, inasmuch as non-NMDA receptor antagonists  are 
able to prevent this early phase of glutamate toxicity. A later phase of glutamate-induced 
excitotoxicity is associated with the excessive and unregulated influx of Na+ and Ca2+ 
through NMDA receptor ion channels, which also induces a mild early neuronal swelling 
(125-127), but is primarily characterized by a slowly developing neuronal degeneration 
that occurs within hours of glutamate exposure (108,119). This delayed  component of 
glutamate-induced injury can be completely prevented by the presence of NMDA receptor 
antagonists or by the removal of extracellular Ca2+ from the exposure buffer (126). 
Subsequent experiments have directly linked 
45Ca
2+ accumulation to the resultant delayed 
neurodegeneration observed after glutamate  exposure in cortical neurons (108). Thus, '4 
these data show that glutamate-induced neurodegeneration is produced by prolonged, 
generalized increases in cytoplasmic calcium which accumulates subsequent to excessive 
NMDA receptor activation (117-119). 
Not all neurons undergo an excitotoxic response when exposed to exogenously 
applied glutamate, however. Experiments utilizing cultured cerebellar granule cells 
(CGCs) indicate that even high concentrations of glutamate are non-toxic when exposure 
occurs in a physiologic milieu. CGCs apparently have the ability to maintain ionic 
homeostasis in the face of ion flux induced by glutamate stimulation (118,128,129). Non-
physiologic conditions which simulate those occurring in CNS pathologies, such as 
depletion of neuronal energy reserves (117,118) or depolarization induced by K+ or 
veratridine  (130-132),  are  therefore  required  to  produce  glutamate-induced 
neurodegeneration in CGCs. Glutamate toxicity is also facilitated in CGCs by the 
omission of Mg2+ from the exposure medium (133,134). Thus, a critical element in the 
transformation of glutamate from neurotransmitter to neurotoxin is the ability to produce 
a depolarizing stimulus of sufficient magnitude to induce release of the voltage-dependent 
Mg2+ blockade of NMDA receptor ion channels (117,118,129) The ability  to maintain 
membrane potentials is therefore an important determinant of neuronal survival, for 
example, in the penumbra of a stroke focus where oxygen availability and neuronal 
energy reserves are partially compromised. 
As mentioned previously,  the  delayed neuronal  degeneration  that  occurs 
subsequent to pathologic NMDA receptor activation is mediated by sustained increases in 
free cytosolic Ca2+ (108,126,132) Homeostatic mechanisms which normally control 
[Ca- ]j may therefore be overloaded or compromised during cerebral pathological states. 
These mechanisms include: Ca2+ extrusion by plasma membrane Ca2+-ATPase (135) and 
the NallCa2+ exchanger (136), Ca2+ buffering by Ca2+-binding proteins (137), and Ca2+ 
uptake into endoplasmic reticulum (138) and mitochondria (139-142). Of  the Ca2+ 
extrusion mechanisms, Ca2+-ATPase is a high affinity, low capacity system (142), 15 
whereas the Na+/Ca2+ exchanger manifests lower affinity but possesses a much higher 
capacity for Ca" extrusion (142). Therefore, the Na+/Ca2+ exchanger is likely the major 
route for extrusion of the micromolar levels of [Ca- that accumulate during intense 
glutamate receptor stimulation  (143,144).  In cultured cerebellar granule neurons, 
cytosolic Na+ concentrations have been estimated to increase to as high as 60-100 mM 
during excitotoxic glutamate exposures (144,145). Alterations of this magnitude in the 
Na l- gradient are known to impair or even reverse Na+/Ca2+ exchanger function (142): 
therefore, a net Ca2+ influx may actually occur through the Na+/Ca2+ exchanger during 
toxic glutamate exposures. With Ca2+ extrusion mechanisms impaired, cytosolic Ca2+ 
must instead be handled through buffering and sequestration mechanisms. Of these two 
mechanisms, mitochondrial Ca-
7+  uptake has been shown to play a dominant role in 
calcium  buffering  during  excitotoxic  glutamate  exposures  (110,146).  Although 
mitochondrial  metabolism  is  stimulated  by  the  physiological  [Ca
2+  increases 
encountered during normal cellular functioning, prolonged exposures to high [Ca2li are 
known to uncouple electron transfer from ATP synthesis (147,148) and induce free 
radical production (149). Ca2+-induced free radicals oxidatively damage mitochondria 
(and  other  cellular  components),  ultimately  reducing  neuronal  energy  reserves 
(109.110.150) and impairing active Ca2+ extrusion and sequestration mechanisms. Thus, 
early mitochondrial dysfunction plays a key role in glutamate neurotoxicity (110). 
In addition to inducing oxidative mitochondrial damage and inhibiting energy 
metabolism, sustained elevations in cytoplasmic Ca2+ are thought to produce cytotoxicity 
through mechanisms which reflect  disruption of intracellular processes normally 
regulated by Ca2+ availability (151). Several simultaneous injury processes are therefore 
likely to occur. Among these processes, activation of catabolic enzymes may play a major 
role. For example calpain, a neutral protease, is involved in the enzymatic cleavage of 
several structural proteins including tubulin, microtubule-associated proteins, spectrin and 
neurofiliment polypeptides  (152).  Calpains have been shown to be involved  in 16 
postischemic neuronal degeneration in the hippocampus (153-155). Moreover, the 
involvement of proteases in excitotoxicity is supported by the suppressive effects of 
protease inhibitors, such as calpistatin, on postischemic hippocampal damage (156.157). 
Elevated cytosolic Ca2+ may also activate phospholipases, resulting in cell membrane 
degradation and liberation of arachidonic acid (158). Arachidonic acid metabolism by 
oxidases leads to the production of oxygen free radicals and peroxidative degradation of 
lipids and other cellular elements (159). Oxygen free radicals are also generated 
subsequent to the conversion of xanthine dehydrogenase to xanthine oxidase by a Ca2+­
activated protease (109,160). Furthermore, sustained cytosolic Ca2+ elevations produce 
neurodegeneration through the activation of nitric oxide synthase (161). NO rapidly reacts 
with oxygen free radicals to form the peroxynitrite radical (ON00 ).  Subsequent 
interaction with hydrogen peroxide, a product of superoxide dismutase activity, produces 
highly toxic hydroxyl radicals. The notion that NO mediates neuronal injury is supported 
by the recent finding that cortical neurons cultured from neuronal nitric oxide synthase­
deficient mice are resistant to glutamate-induced cytotoxicity (162). 
A number of studies have shown that Ca2+ overload can trigger endonuclease 
activation. Endonucleases play a central role in programmed cell death, or apoptosis 
(163,164). Recent studies have shown that some neuronal subpopulations may die via 
apoptosis following activation of this endogenous cell death program by glutamate (165­
169). Moreover, in cultured cerebellar granule neurons, neuronal death has been 
demonstrated to result from either apoptosis or necrosis, depending  on the severity of 
neuronal injury and extent of mitochondria] dysfunction induced by excitotoxin exposure 
(170). 17 
1.2.2  AMPA/kainate Receptor-Mediated Toxicity 
Some exogenous EAAs, such as kainate and domoic acid, interact specifically 
with non-NMDA receptors yet induce a calcium-dependent CNS toxicity similar to 
glutamate (171,172). The mechanisms by which these AMPA/kainate receptor agonists 
produce Ca2+-mediated neurotoxicity are as yet uncertain. In a number of vitro systems 
AMPA/kainate  receptor-mediated  neurotoxicity  is  largely  dissociated  from  the 
involvement of NMDA receptors, since NMDA receptor antagonists fail to protect 
against non-NMDA receptor agonist challenge (173,174). Moreover, only a prolonged 
exposure to AMPA/kainate receptor agonists produces neuronal degeneration in some 
experimental systems (4,174), while acute exposures are sufficient to kill neurons in 
others (175-177). Thus, whereas the toxicity of glutamate can be clearly linked to NMDA 
receptor  activation  and  subsequent  calcium  entry,  the  mechanisms  underlying 
AMPA/kainate receptor-mediated, calcium-dependent neurodegeneration have not been 
well defined in cell culture systems. 
In contrast to the in vitro data, however, studies in animals indicate that 
AMPA/kainate receptor agonist-induced neurotoxicity is mediated by NMDA and  non-
NMDA receptors. Furthermore, domoic acid administered systemically to rats and 
monkeys produces acute neurotoxicity and is rapidly cleared from the circulation 
(178,179). In the rat, kainic acid produces siezures followed by necrosis ofneurons in the 
hippocampus. amygdala, piriform cortex and other limbic areas (13.14.180). Several 
classes of competitive and non-competitive NMDA receptor antagonists have been shown 
to prevent the majority of this seizure related toxicity (14,180-182). Moreover, chemical 
denervation of hippocampal mossy fiber tracts from granule  neurons of the dentate gyrus 
substantially attenuates domoate (182) and kainate-induced (183,184) toxicity in CA3 
neurons. These observations provide evidence consistent with the hypothesis that synaptic 18 
activity and NMDA receptor activation play a role in non-NMDA receptor agonist-
mediated neurotoxicity. 
Given the discrepancies between the in vitro and in vivo data, it is probable that 
AMPA/kainate  receptor  agonists  produce  cytotoxicity  through  several  possible 
mechanisms. One route by which AMPA/kainate receptors could elevate cytosolic Ca2+ to 
toxic levels is through a depolarization-dependent activation of voltage operated Ca2± 
channels (186). The involvement of voltage activated Ca2+ channels is supported by the 
finding that the dihydropyridine, nifedipine, substantially attenuates slow AMPA/kainate 
receptor-mediated  neurotoxicity  in  cultured mouse  cortical  neurons  (187),  and 
nimodipine has been shown to significantly attenuate lesions produced by kainate injected 
intracerebrally in rats (188). Large cytosolic Na+ accumulations that occur subsequent to 
AMPA/kainate receptor agonist exposure may also induce a reversed mode of operation 
of the Na+ /Ca
2+ exchanger (144). This route of Ca/-1- entry could be particularly important 
during kainate and domoate exposures, inasmuch as these agonists induce mostly non-
desensitizing electrical responses in neurons, depending on which non-NMDA receptor 
subunits are expressed (68). Recent reports have demonstrated the presence of Ca2+­
permeable AMPA/kainate receptors in a subpopulation of neurons and glia (74,189). 
These neurons have been shown to be particularly vulnerable to non-NMDA agonist-
induced toxicity (189). Thus, although NMDA receptor-mediated increases in cytosolic 
Ca2+ concentration are a major cause of excitatory amino acid-induced injury and death in 
neurons, non-NMDA receptors alone may produce cytotoxic increases in intracellular 
Ca2+ concentration. 
As alluded to previously, one other potential route for AMPA/kainate receptor-
mediated Ca2+ entry into neurons is through the NMDA receptor ion channel. NMDA 
receptors would be activated subsequent to non-NMDA receptor agonist-induced 
glutamate release (190,191). Moreover, because some AMPA/kainate receptor agonists 
are capable of activating non-desensitizing currents in neurons, in contrast to the rapidly 19 
desensitizing currents induced by glutamate. release of the Mg2+ blockade of NMDA 
receptor ion channels would be facilitated (68). In support of this notion. extracts from 
mussels contaminated with subtoxic concentrations of domoic acid have been shown to 
potentiate synergistically the excitotoxic effect of glutamate and aspartate in cultured 
cerebellar granule neurons (174). 
1.3 Development of an In Vitro Model of Glutamate- and Domoate-
Induced Toxicity Using Cultured Rat Cerebellar Granule Neurons 
Primary cultures of rat cerebellar granule neurons represent a valuable model for 
studying the physiology, biochemistry and toxicology of excitatory amino acids (EAAs) 
because they can be cultured as a relatively homogenous cell population of greater than 
90% purity (192), express both metabotropic (193) and ionotropic (194) glutamate 
receptors, and form an extensive network of neurites and synaptic contacts (192). 
Cerebellar granule neurons are also sensitive to EAA-mediated cytotoxicity (116­
118,128). 
When grown in a serum-containing medium, cerebellar granule neurons develop a 
survival requirement for depolarizing conditions between two and four days in vitro 
which, if not met by elevated extracellular concentrations of K+ or NMDA. results in a 
significant cell loss by the end of one week in culture (192,195). Neuronal depolarization 
is believed to mimic the trophic influence of the first innervation received by post-
migratory granule cells from glutamatergic mossy fibers in vivo (195,196). Depolarizing 
conditions also affect the regulation and developmental timecourse of glutamate receptor 
expression (197-201) with the consequence that the pharmacology of agents acting  on 
glutamate receptors changes both as a function of growth conditions and age of neurons 
in culture (197,198,200,202). In this thesis project, cerebellar granule  neurons were 
utilized at a single age of 12 days in culture (DIC). Neurons at this age express both 20 
NMDA and non-NMDA receptor subtypes and respond to excitatory amino acids in a 
characteristic and reproducible manner (203,204). In Chapter 5, the pharmacologic and 
toxicologic significance of NMDA receptors expressed in 12 DIC cerebellar granule 
neurons (CGCs) is  investigated, and the effect of chronic depolarization on the 
developmental regulation of NMDA receptor subunit expression is discussed (204). 
The effect of chronic depolarization on AMPA receptor subunit expression and 
the functional activity of AMPA receptors has also been investigated in CGCs (201). 
although not as rigorously as with NMDA receptors. In granule cells of the adult rat 
cerebellum, AMPA receptors have been shown to be composed primarily of GluR2 flip 
and G1uR4 flop subunits (23). When grown under standard culture conditions (with 25 
mM 1(±), however, CGCs have been shown to express high levels of GluR1 mRNA and 
protein in addition to G1uR2, G1uR3 and G1uR4 subunits (85,201). Therefore, AMPA 
receptors on CGCs may contain various combinations of all four AMPA receptor 
subunits. The effect of growth conditions on kainate receptor subunit expression in CGCs 
has not yet been characterized; however, GluR6 and KA2 subunits are known to be 
expressed in cerebellar granule neurons in vivo (23), and pharmacological studies show 
kainate receptors to be present in CGCs (194). Thus, CGCs express both AMPA and 
kainate receptor subtypes. 
An important consideration when using CGCs for toxicologic experimentation is 
that exposure conditions must be manipulated to overcome the inherent resistance that 
CGCs have to the cytotoxic effects of excitatory amino acids (EAAs) (117,118,129,133). 
Moreover, the specific experimental conditions employed  may affect the intensity of 
neuronal injury induced by EAAs and the pathways through which the neuronal damage 
occurs (4,109,110,115,117,118). To induce glutamate toxicity,  for example, non-
physiological exposure conditions have been employed which mimic those occurring in 
CNS pathologies. In this experimental context, CGCs provide  an appropriate model for 
studying the cytopathologic mechanisms of such diseases  as stroke, trauma and hypoxia 21 
(117,118,129,133,144-146, i70,191,203). For non-NMDA receptor agonists such as 
domoate, however, an appropriate model should utilize a physiologic exposure milieu, 
inasmuch as domoate intoxications are known to occur in initially healthy individuals 
(10,11). A physiologic milieu would preserve both normal cell signaling mechanisms by 
maintaining the voltage-dependence of NMDA receptor currents, and the functional 
interrelationships that exist between NMDA and AMPA/kainate receptors. 
In the current project, it was intended that neurotoxicological experiments be 
designed so that NMDA and AMPA/kainate receptor agonist-induced toxicity occur 
under identical exposure conditions, thereby allowing direct comparisons to be made 
between domoate excitotoxic mechanisms and the well characterized mechanisms of 
glutamate-induced toxicity. This required that the resistance possessed by CGCs to 
glutamate challenge  in  a physiologic exposure milieu  (i.e.  non-depolarizing K+ 
concentration with Mg2+ and glucose present) be overcome by reducing the exposure 
temperature from 37° to 22°. The facilitation of acute glutamate toxicity in CGCs by 
reduced temperature is characterized in Chapter 2 of this manuscript (203). In Chapter 3, 
this characterization is extended by examining how reduced temperature affects CGC 
membrane potential during glutamate challenge. In Chapter 4, glutamate- and domoate­
induced neurotoxicity are compared directly in CGCs using the previously defined 
exposure conditions, and the cellular mechanisms of domoate-induced cytotoxicity are 
addressed. 1.4  References
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2.1 Abstract 
We have defined conditions whereby glutamate becomes toxic to  isolated 
cerebellar granule neurons in a physiologic salt solution (pH 7.4). Under these conditions. 
acute glutamate excitotoxicity manifest only when the temperature was reduced from 37° 
C to 22°C. N-methyl-D-aspartate (NMDA) was non-toxic at either temperature at 
concentrations as high as  1 mM. Glycine strongly potentiated both the potency and 
efficacy of glutamate, but revealed only a modest NMDA response. The non-NMDA 
receptor antagonist, 6-cyano-7-nitroquinoxalinedione (CNQX), potently protected against 
glutamate challenge. although the contribution of antagonism at strychnine-insensitive 
glycine sites could not be excluded. To further characterize the non-NMDA receptor 
contribution to the excitotoxic response, the promiscuity of glutamate interaction with 
ionotropic receptors was simulated by exposing neurons to NMDA in the presence of 
non-NMDA receptor agonists. NMDA toxicity was potentiated four to seven fold when 
non-NMDA receptors were coactivated by a subtoxic concentration of AMPA. kainate or 
domoate. These results suggest that non-NMDA receptor activation participates in the 
mechanism of acute glutamate toxicity by producing neuronal depolarization (via sodium 
influx) which in turn promotes the release of the voltage-dependent magnesium blockade 
of NMDA receptor ion channels. 
2.2 Introduction 
The mechanisms responsible for the transition of glutamate from excitatory CNS 
neurotransmitter to neurotoxin have been studied extensively in various in vitro systems. 
In cultured murine cerebral cortical neurons, two distinct components of this glutamate-
induced excitotoxicity have been elucidated (1,2). An early component, mediated by the 
depolarization-dependent influx of Na+, Cl and water, manifests as a rapidly developing 42 
neuronal swelling that is reversible if either glutamate concentration or exposure duration 
are limited (3,4). The early component has been linked to activation of non-N-methyl-D­
aspartate (non-NMDA) receptors and can therefore be mimicked by non-NMDA receptor 
agonists such as kainate, domoate or AMPA; however, prolonged exposures are required 
for these compounds to induce significant lethality (2,5). The second component of 
glutamate-induced cytotoxicity has been associated with the excessive and unregulated 
influx of Ca-HE through NMDA receptor ion channels, which also induces a mild early 
neuronal swelling (3,4,6), but is primarily characterized by a slowly developing neuronal 
degeneration that occurs within hours of a brief (5  minute) exposure to high 
concentrations of glutamate or NMDA (7,8). 
Glutamate, which displays activity at all excitatory amino acid receptor subtypes, 
stimulates both the early and delayed components of the excitotoxic response. Non-
NMDA receptor antagonists confer protection against the majority of the early neuronal 
swelling but not the later neuronal degeneration (9). Conversely, NMDA receptor 
antagonists only partially reduce the acute neuronal swelling, yet protect against the 
delayed neuronal degeneration (5,10). 
In cultured rat cerebellar granule neurons, glutamate excitotoxicity is also 
mediated by Ca+ entry through NMDA receptors (11,12). However, cerebellar granule 
neurons differ in their relative resistance to these glutamate-induced effects. When 
cerebellar granule neurons are exposed in a physiologic milieu at 37°C, glutamate is non­
toxic even at high concentrations, revealing an apparent ability of these  neurons to 
maintain ionic homeostasis in the face of ion flux induced by agonist stimulation (13-15). 
Specific manipulations, such as the omission of Mg++ from the exposure medium, are 
therefore required for glutamate to induce toxicity (16,17). Excitotoxicity in cerebellar 
granule neurons is also facilitated by the depletion of neuronal energy reserves (14,18), or 
by depolarization induced by elevated K+ or exposure to veratradine (19-21). The 
neurons then undergo either rapid or delayed neuronal degeneration, depending  upon the 43 
duration and intensity of glutamate exposure. These data indicate that in a physiologic salt 
solution cerebellar granule cell excitotoxicity manifests only when presented in the 
context of an independent depolarizing stimulus sufficient to allow release of the voltage-
dependent Mg++ blockade of NMDA receptor ion channels, thereby resulting in 
excessive influx of Na+ and Ca++ (22-24). 
Questions remain however,  as  to how NMDA and non-NMDA receptor 
mechanisms might be functionally integrated in the excitotoxic response to glutamate and 
other excitotoxins, since exposure conditions utilized in studies involving cerebellar 
granule neurons are often permissive to the direct activation of NMDA receptors by 
excitatory amino acid agonists. In the present study, we define conditions that unmask 
glutamate toxicity in a physiologic salt solution, and in the absence of additional 
depolarizing stimuli. These conditions leave receptor and homeostatic regulatory 
functions intact. We report herein that glutamate becomes acutely toxic  to cerebellar 
granule neurons when the exposure temperature  is  reduced. Moreover, we have 
delineated the NMDA and non-NMDA receptor mediated components of this  acute 
glutamate-induced neurotoxicity. 
2.3 Materials and Methods 
2.3.1 Materials 
(RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA), D(-)­
2-amino-5-phosphonopentanoic  acid  (D-AP5),  6-cyano-7-nitroquinoxaline-2,3-dione 
(CNQX), and domoic acid were purchased from Tocris Cookson (Bristol, U.K). 3-amino­
l-hydroxy-2-pyrrolidone (HA-966) was purchased from Research  Biochemicals Inc. 
(Natick, MA). L-glutamate, glycine, kainic acid, N-methyl-D-aspartic acid (NMDA), 44 
bovine serum albumin (BSA). trypsin, DNAse and soybean trypsin inhibitor (SBTI) were 
purchased from Sigma (St. Louis, MO). Basal Eagle's Medium (BME) was purchased 
from Gibco Labs (Grand Island, N.Y.). 
2.3.2 Cell Culture 
Primary cultures of cerebellar granule neurons were obtained from 8 day old 
Sprague Dawley rats as described previously (18), with minor modifications. Cerebella 
were isolated and placed in Kreb's buffer containing 3 mg/ml bovine serum albumin and 
1.2 mM MgSO4 (KB/BSA), minced by mild trituration, washed once in KB/BSA and 
incubated with shaking for 15 minutes at 37°C in 30 ml KB/BSA containing 2200 U /mi 
trypsin. The digestion was terminated by addition of 15 ml KB/BSA containing 26 tg /ml 
DNAse, 166 .tg /ml soybean trypsin inhibitor (SBTI) and 1.7 mM MgSO4. Following low 
speed centrifugation for 1 minute, the tissue was resuspended in KB/BSA containing 80 1,1 
g/ml DNAse, 500 1.1g/m1 SBTI and 2.8 mM MgSO4, triturated with a Pasteur pipette and 
the suspension allowed to settle. The supernatant, containing dissociated cells,  was 
transferred to another tube and the trituration repeated on the remaining undissociated 
tissue. The supernatants were combined, centrifuged at low speed for five minutes and the 
cell pellet resuspended in basal Eagle's medium containing 25 mM KC1, 2 mM glutamine, 
10% fetal calf serum and 100 4g/m1 gentamicin. The cells were seeded onto poly-l-lysine 
coated (5  tg /ml) 35mm polystyrene culture dishes (Corning) at a density of 2.5 x 105 
cells/cm2. Care was taken to ensure a uniform neuron distribution by thorough mixing of 
the suspension after addition to each plate. Cells were incubated at 37°C in a 5% CO2, 
95% humidity atmosphere. Cytosine arabinoside (10 1.1M) was added 18-24 hrs later to 
inhibit the replication of non-neuronal cells. At 8 days in culture, 100 ill of a 25 mg/ml D-
glucose solution was added to each plate to replenish energy resources and to compensate 
for growth media evaporative losses (25). 45 
2.3.3 Excitotoxicity Assays 
Cerebellar granule neurons were utilized at 12 days in culture. Excitotoxicant 
exposure was conducted at a temperature of 22°C. Prior to agonist exposure, growth 
medium was removed and the cultures exposed for 5 minutes to 1 ml Locke's incubation 
buffer containing (in mM): 154 NaCI; 5.6 KC1; 1 Mg Cl; 2.3 CaCI; 5.6 glucose; 8.6 
HEPES; pH 7.4. The Locke's buffer was then replaced with 1 ml of fresh Locke's solution 
containing experimental compounds and the cultures were then incubated for 2 hrs. At the 
termination of the exposure, 0.6 ml of the incubation buffer was collected for analysis of 
LDH activity, and the neurons were washed three times in fresh Locke's solution. The 
neurons were then maintained for a one hour post-exposure incubation prior to a five 
minute staining with the vital dye fluorescein diacetate (5 µg /ml) (26). Ethidium bromide 
(10 41 of a 50 p.g/m1 solution) was added four minutes after the fluorescein diacetate to 
stain the nuclei of nonviable neurons. The dye solution was replaced with fresh Locke's 
and the neurons placed on an inverted microscope (Zeiss model 1M35) equipped with 
fluorescence optics. Under fluorescence, soma and neurites of live neurons appear bright 
green in color whereas dead neurons do not accumulate fluorescein. Nuclei of dead 
neurons, that are not washed away. appear red due to ethidium bromide staining. 
2.3.4 Assessment of Neuronal Viability 
Five to six randomly selected fields from each plate were photographed at 80x 
magnification. Live neurons were counted from the photographic slides and the results 
averaged for each concentration. Results were referenced to the  average control culture 
populations processed in parallel to experimental plates. 
LDH activity of the incubation buffer was assayed as described previously (27). 
Aliquots (0.2 ml) of incubation buffer were added to 2.3 lirnol sodium pyruvate and 0.2 46 
mg NADH, each in 0.5 ml of 0.1 M KHPO4 buffer (pH 7.5), for a total assay volume of 
1.2 ml. The change in absorbance at 340 nm was measured with a UV spectrophotometer 
and LDH activity calculated from the linear portion of the slope of the absorbance curve. 
LDH concentration was expressed in units/ml, where one unit is the amount of LDH that 
produces a decrease of 0.001 absorbance units per minute per ml of incubation medium. 
LDH efflux at each drug concentration was determined from triplicate plates and the 
results averaged. 
2.3.5 Data Analysis 
EC50 values and maximum responses for excitotoxicants were determined by 
nonlinear least squares fitting of a logistic equation to concentration  response data. 
Nonlinear regression analysis was performed with Graphpad Inplot software (San Diego, 
CA). These data were analyzed according to the following equation where Y equals the 
response, C is the EC50, [X] is the agonist concentration, D the slope factor and A and B 
the minimum and maximum plateaus of the concentration-response curve: Y = A + (B­
A)/1+(C/P(1)D 
2.4 Results 
Initial experiments confirmed that glutamate and NMDA  are nontoxic even at 
millimolar concentrations when tested at 37°C in  a physiologic salt solution (data not 
shown). In contrast, at 22°C glutamate induced a concentration dependent reduction in 
the number of viable neurons (EC50 = 84.2 1.LM), while NMDA remained non-toxic  at 
concentrations as high as 1 mM (Fig. 2.1). The maximal neurotoxic response to glutamate 
represented a 50% reduction in the number of viable  neurons. The initial cytotoxic 
response, as evidenced by neuronal swelling, could be visualized by light microscopy as 47 
early as ten minutes after exposure to glutamate; however, the maximal excitotoxic 
response appeared only after a 90 to 120 minute incubation. A one hour incubation in 
fresh Locke's solution subsequent to glutamate exposure improved the ability of surviving 
neurons to be stained with fluorescein diacetate, thereby improving visualization and 
quantification of viable neurons. The results of LDH efflux assays correlated closely with 
data obtained by the direct counting method and provided independent confirmation of 
excitotoxic cell injury (fig.2.1) 
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Fig. 2.1 Comparison of the excitotoxic concentration-response relationship for glutamate 
(0) and NMDA (0)(0,0 = live count; , = LDH efflux) at 22°C. Incubations were 
carried out in Locke's buffer containing 5mM K+ without added glycine. Individual 
points represent mean ± SEM from a representative experiment for NMDA and three 
separate experiments for glutamate. Individual experiments were performed in triplicate. 
Inasmuch as glycine is known to be required  as a coagonist for glutamate 
activation of the NMDA receptor, the effect of exogenous glycine on the response to 48 
glutamate and NMDA was investigated. In the presence of 10 pM glycine, the potency of 
glutamate was increased approximately two-fold; from a control EC50 of 84.2 pM to a 
value of 43.4 pM in the presence of glycine. A maximal five-fold augmentation of 
glutamate potency occured when 100 pM glycine was included in the incubation buffer 
(glutamate EC50 = 17.9 pM). Glycine also increased modestly the efficacy of glutamate 
from a maximum neuronal loss of 50% to 65% (Table 2.1). Similarly. the toxicity of 
NMDA was enhanced in the presence of 100 p.M glycine, but remained at  a much lower 
potency (EC50 = 354 1.1M) and efficacy (30% neuron loss) than glutamate (Fig.2.2a and 
2.2b). 
TABLE 2.1 The effect of glycine on the excitotoxic potency 
and efficacy of glutamate. 
Glycine  Glutamate EC50  Efficacy 
(gm)  (im)a  (% neuron loss)b 
0  84.2 (75.8-93.5)  50 (47.8-52.4) 
10  43.4 (40.8-46.2)  55 (53.9-56.1) 
100  17.9 (15.8-20.4)  65 (59.1-70.3) 
aEC50 values are based upon direct neuron counts. bValues 
in parentheses represent 95% confidence intervals. Data 
represent the mean of 3-4 separate experiments performed 
in triplicate. 
To further the pharmacological characterization of glutamate toxicity in cerebellar 
granule neurons, the effects of NMDA and non-NMDA receptor antagonists against a 
maximal glutamate (300 gM) challenge were assessed (Fig. 2.3). The competitive NMDA 
receptor antagonist D-2-amino-5-phosphonopentanoic acid (D-AP5), completely  and 
concentration dependently protected against glutamate toxicity (EC50 = 22.8 pM), thus 
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Fig. 2.2 (a) NMDA becomes toxic in the  presence of 10011M glycine. Data points 
represent the mean ± SEM of three separate experiments performed in  triplicate. 
EC50.3544M (202-62211M); (b) Comparative glutamate concentration-response (100gM 
glycine present) from a representative experiment performed in triplicate. EC50=17.9p.M 
(l5.8-20.4gM). The magnitude of LDH efflux corresponded to the maximum cell loss for 
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Fig. 2.3 Antagonist concentration-response against a 3001.IM L-glutamate challenge. The 
competitive NMDA receptor antagonist D-AP5 (o) and the strychnine insensitive glycine 
site antagonist HA-966 (A), were tested without the addition of glycine. CNQX was 
tested with (0) and without () the addition of 1001.tM glycine. Data points represent the 
mean ± SEM of at least three separate experiments performed in triplicate. 
response. In accordance with the neuroprotective actions of D-AP5, the strychnine-
insensitive glycine site antagonist HA-966 was fully protective (EC50  = 95.7 [(M). The 
addition of the non-NMDA receptor antagonist CNQX to cultures also afforded complete 
protection against glutamate challenge (EC50  = 9.1 iiM). The CNQX neuroprotection 
concentration-response curve could be shifted rightward by exogenous glycine (Fig. 2.3), 
indicating that CNQX neuroprotection may derive partially from its known  ability to 
displace glycine from strychnine-insensitive binding sites on NMDA receptors. 
Since NMDA is a much less potent excitotoxin than glutamate  under the 
conditions employed, we determined whether the toxicity of this  selective agonist could 51 
be enhanced in the presence of low concentrations of non-NMDA receptor agonists. in 
effect simulating the promiscuity of glutamate at NMDA and non-NMDA  receptors. 
Concentration-response curves were generated for kainate, domoate and AMPA, and 
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Fig. 2.4 Concentration-response relationships of non-NMDA  receptor agonists. (0) 
Domoate EC50.1.5104 (1.31-1.74i,tM); (o) Kainate EC50=20.2pM (16.1-25.411M); (A) 
AMPA. Experiments were carried out in the  presence of 100p,M glycine. Values in 
parentheses represent 95% confidence intervals. 
The subthreshold concentrations chosen for kainate and domoate were 7 pM and 0.2 pM 
respectively. AMPA had no effect on neuron viability or LDH efflux at concentrations as 
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Fig. 2.5 NMDA concentration-responses in the presence of non-NMDA receptor agonists. 
Non-NMDA agonist concentrations were those for which little or no effect was observed 
alone: (a) 71.1M kainate(A); (b) 0.2pM domoate(0); (c) 301IM AMPA(o).  Data points 
represent mean ± SEM of three separate experiments. LDH efflux performed in triplicate 
for each experiment. 53 
greater. An AMPA concentration of 30 pIVI was therefore chosen for the NMDA 
interaction experiments. 
NMDA-induced cytotoxicity, as measured by LDH efflux, was enhanced in the 
presence of these non-NMDA receptor agonists (Fig. 2.5a-c and Table 2.2).Kainate and 
domoate potentiated the EC50 values for NMDA cytotoxicity from a control value of 354 
pM to EC50 values of 106 pM and 105 pM respectively. Kainate and domoate 
potentiated the EC50 values for NMDA cytotoxicity from a AMPA also increased the 
potency of NMDA, reducing the EC50 to 125 pM. When assessed by direct counting of 
fluorecsein stained neurons, the potentiation of NMDA-induced neurotoxicity by non-
NMDA receptor agonists manifested as a four to seven-fold leftward shift in the 
TABLE 2.2 The effect of non-NMDA receptor agonists on 
the excitotoxic potency and efficacy of NMDA. 
Non-NMDA  NMDA EC50  Efficacy 
Agonista  (% neuron loss)c (,tM)b 
Control  354.0 (201.5-621.8)  30 (_30) 
Kainate  105.5 (71.6-155.5)  36 (28-44) 
(71.IM) 
Domoate  104.7 (80.4-136.4)  45 (38-52) 
(0.2pM) 
AMPA  124.7 (104.9-148.3)  37 (31-43) 
(30W) 
allon-NMDA  receptor  agonists  were  present  at 
concentrations that cause no loss of neurons. bEC50 values 
are  based  upon LDH efflux  data.  cValues  within 
parentheses  represent 95% confidence  intervals.  Data 
represent the mean of 3 experiments performed in triplicate. 54 
concentration-response curve. Moreover, the efficacy of NMDA was also increased. 
although remaining somewhat lower than the maximal level of neuron loss occuring in 
response to glutamate. 
2.5 Discussion 
Previous reports have shown that  cultured cerebellar granule neurons are 
completely resistant to high concentrations of glutamate when exposure occurs in a 
physiologic salt solution, but sensitive to low glutamate concentrations upon glucose 
deprivation or removal of Mg++ from the exposure medium. Thus a pivotal event in the 
induction of glutamate toxicity appears to be the release of the voltage-dependent Mg++ 
blockade of NMDA receptor ion channels (14-16). In agreement with these reports, we 
have confirmed that cerebellar granule neurons are resistant to glutamate when exposed 
in a physiologic salt solution at 37°C. In contrast, we have shown that toxicity to 
glutamate can be unmasked in a physiologic salt solution when the exposure temperature 
is reduced from 37° to 22°. Low temperature potentiation of glutamate excitotoxicity in 
cultured cerebellar granule neurons has been previously noted (28). In the present report, 
we have confirmed and extended these findings through a delineation of the roles of both 
NMDA and non-NMDA receptors in glutamate-induced neuronal death in a physiologic 
salt milieu. 
Several mechanisms may account for the facilitation of excitatory amino acid 
toxicity by low temperature. One possibility is that a reduction in the rate of glutamate 
uptake, coupled with a reduction in the rate of enzyme activities involved in the 
maintenance of energy charge or ion homeostasis, would impair both the ability of the 
neurons  to  limit  glutamatergic  stimulation  and  to  sustain  a  transmembrane 
electrochemical potential of sufficient magnitude to preserve the voltage-dependent Mg+ 55 
+ block. High affinity L-glutamate uptake in brain slices and synaptosomes is temperature 
sensitive (29). Inasmuch as the rate of enzyme catalyzed reactions generally decreases 
with reduced temperature, it is reasonable to propose that the observed sensitivity to 
glutamate may be caused primarily by a reduction in the activity of Na+/K+ ATPases, 
since the maintenance of Na+ and K+ gradients and therefore the neuronal resting 
potential is known to be a primary function of these enzymes. In sheep cardiac Purkinje 
fibers, the Q10 for Na+/K+ ATPase current transients has been shown to be between 1.6 
and 2.3 over the temperature range of 26-46°C (30). Moreover, electrophysiological 
experiments in cultured rat skeletal myotubes demonstrated that Na+/K+-ATPase activity 
accounts for about 30% of the resting membrane potential (31). This component of the 
resting potential in  skeletal muscle myotubes could be completely and reversibly 
eliminated by reducing the temperature from 35°C to 10°C, an effect equivalent to that 
observed when the myotubes were treated with ouabain. In hippocampal CA 1 neurons, 
the sodium pump has been shown to contribute significantly to the hyperpolarization that 
occurs subsequent to glutamate-induced depolarizations (32). This hyperpolarization 
following glutamate challenge was inhibited to the same degree by ouabain or low 
temperature. Na+/K+ ATPase inhibition has also been shown to enhance excitotoxic 
responses in a variety of experimental systems. For instance, inhibition of the sodium 
pump by ouabain resulted in a >95% loss of cerebellar granule cells when challenged 
with either glutamate or NMDA in a physiologic medium containing Mg++ (18). This 
effect was also observed in rat cortical neurons whereby the degree of toxicity to 
glutamate varied inversely with the degree of chemical inhibition of Na+/K+-ATPase 
(33). We therefore propose that susceptibility to glutamate challenge in a balanced salt 
solution at 22°C is most likely due to an impaired ability of neurons to respond to 
disturbances in ion gradients, primarily as a result of the temperature-dependent reduction 
in Na+/K+-ATPase activity. The ensuing neuronal depolarization following glutamate 
exposure would facilitate release of the voltage-dependent Mg++ blockade of NMDA 56 
receptor channels, permitting the excessive influx of Ca++ and Na+ with attendant 
excitotoxic cell injury. 
Our initial experiments indicated that a significant neurotoxic response to 
glutamate required a 90 to 120 minute exposure duration and that NMDA was nontoxic 
under these conditions. Addition of glycine increased both the potency and efficacy of 
glutamate and enabled NMDA to evoke a neurotoxic response. These data may be 
compared to those of Novel li, et al. (18), in which virtually all cerebellar granule neurons 
displayed excitotoxic injury after a 30 minute exposure to either glutamate or NMDA at 
37°C when Mg++ or glucose were omitted from the incubation medium. Complete 
inhibition of the sodium pump by ouabain similarly facilitated the loss of virtually all 
neurons by exposure to either glutamate or NMDA. Our results differ from these previous 
reports in that we observed NMDA to be substantially less effective than glutamate as an 
excitotoxin in a physiologic salt solution. This difference in efficacy between glutamate 
and NMDA suggests that agonist binding to NMDA receptors may be necessary but not 
sufficient to induce substantial cytotoxicity in the presence of Mg++. The excitotoxic 
response to glutamate appears to require the concurrent activation of both NMDA and 
non-NMDA receptors. 
The involvement of non-NMDA receptors in glutamate-induced neurotoxicity was 
explored by assessing the ability of the non-NMDA receptor antagonist CNQX to inhibit 
glutamate toxicity. CNQX afforded potent neuroprotectant effects  in response to 
glutamate challenge. Interpretation of this effect of CNQX is complicated somewhat by 
the ability of this compound to act as an antagonist at the strychnine-insensitive glycine 
site on NMDA receptors (34-36). Thus in addition to acting as a non-NMDA receptor 
antagonist, CNQX is nearly equipotent as HA-966 in displacing [3H]glycine from the 
strychnine-insensitive  site  of  the NMDA receptor  (37). CNQX was  however 
approximately ten times more potent than HA-966 in attenuating neurotoxicity (fig. 2.3). 
This difference in the relative potency of CNQX and HA-966 as neuroprotectants  as 57 
compared to their affinity for the [3H]glycine site may indicate that the observed 
neuroprotection is due, at least in part, to antagonism of glutamate at non-NMDA 
receptors. Similary, the glycine-induced rightward shift in the CNQX concentration-
response relationship may be related to the ability of glycine to enhance the affinity of 
glutamate for NMDA receptors (38-41). The observation that glycine enhanced the 
excitotoxic potency of glutamate and NMDA provides evidence that the sensitivity of 
NMDA receptors to agonist activation was indeed augmented by this coagonist (fig. 2.2). 
This positive heterotropic effect of glycine on the interaction of glutamate with the 
NMDA receptor may underlie the glycine-induced rightward shift  in the CNQX 
concentration-response relationship. 
Another approach to assess the participation of non-NMDA receptors in the acute 
neurotoxic response to glutamate was to ascertain the influence of concurrent non-NMDA 
receptor activation on the response to NMDA, thereby simulating the promiscuity of 
glutamate at both classes of receptor. Although the subtoxic concentrations of non-
NMDA receptor agonists employed produced only minor somal swelling in the absence 
of NMDA, they reduced NMDA LC50 values by more than three fold and increased 
neuronal cell loss 20 to 50 percent. Thus concurrent non-NMDA receptor activation 
enables NMDA receptor stimulation capable of producing a neurotoxic response. 
It  is noteworthy that AMPA alone did not cause neuronal death, but rather 
produced only mild neuronal swelling at high concentrations. Expression of AMPA 
receptor subunits has been shown in cultured rat cerebellar granule neurons by Northern 
and Western blotting techniques (42). Therefore, we conclude that either (a) the level of 
AMPA receptor expression is insufficient for AMPA to cause significant toxicity, or (b) 
rapid desensitization of AMPA receptors precludes production of significant toxicity 
under the conditions of these experiments when AMPA is used alone (43,44). Neither of 
these two possibilities necessarily precludes the potentiation of NMDA toxicity by 
AMPA receptor activation. Nonetheless, AMPA also exhibits a low affinity for kainate 58 
receptors (45,46) and elicits small currents in certain heteromeric assemblies of kainate 
receptors (47,48). Thus, interaction with kainate receptors may also contribute to the 
observed effect of AMPA on NMDA-induced neurotoxicity. 
The results described herein emphasize the influence of non-NMDA receptors on 
the excitotoxicity induced by glutamate. This influence is relevant to neuropathologies 
which result from the excessive activation of glutamate receptors.  Activation of non-
NMDA receptors would be expected to produce neuronal depolarization, which would 
facilitate cation influx through NMDA receptor ion channels due to relief of the Mg++ 
blockade. Such a depolarizing influence may be particularly detrimental when neuronal 
function has been compromised by hypoxia or hypoglycemia. Non-NMDA receptor 
antagonists may therefore provide valuable therapeutic benefits against neuropathology 
induced by such neuronal compromise, a notion supported by in vivo studies. Thus, the 
AMPA  receptor  antagonist,  2,3- dihydroxy -6- nitro- 7- sulfamoylbenzo(f)quinoxaline 
(NBQX), produced a protective effect against post-ischemic behavioral pathology and 
hippocampal damage in gerbils when administered as late as one hour after the onset of 
global ischemia (49,50). NBQX was also protective against damage to hippocampal CAI 
pyrimidal neurons (51) and cerebellar purkinje cells (52) in a rat model of ischemia. 
Striatal and cortical injury after insulin-induced hypoglycemic coma in rats was also 
found to be due to stimulation of both AMPA and NMDA receptors (53). The data 
presented in this report provide in vitro results which support the conclusions of in vivo 
studies. 
In conclusion, our results document the effect of reduced temperature to augment 
excitatory amino acid mediated toxicity in cultured cerebellar granule neurons when 
exposure occurs in a physiologic milieu. Moreover, this has allowed us to clearly 
demonstrate that glutamate-induced excitotoxicity  is  dependent on the  functional 
integration of non-NMDA and NMDA receptor activation. These findings suggest a 
mechanism by which non-NMDA receptors contribute to glutamate-induced toxicity and 59 
are consonant with the results of in vivo studies detailing the neuroprotective effect of 
non-NMDA receptor antagonists against CNS pathology induced by ischemia and 
hypoglycemia. 60 
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The membrane potential of cells that are too small to be measured with a 
microelectrode can be determined by methods that use lipophilic  ions such as 
tetraphenylphosphonium (TPP +)  (1).  These compounds permeate  freely  through 
biological membranes, have the propensity for charge delocalization, and therefore 
passively equilibrate with electric potential (2). TPP+ has been used for measuring 
membrane potentials (NY) in neural preparations such as neuroblastoma cells (3), 
neuroblastoma-glioma hybrid cells (4), and in synaptosomes (5-8). In the present study, 
we have estimated AT in cultured rat cerebellar granule neurons (CGCs) in physiologic 
media at 37° and 22° using a variation of the method of Lichtshtein, et al. (4). Inasmuch 
as CGCs are known to be resistant to the toxic effects of glutamate in physiologic media 
at 37° (9-11) but vulnerable at 22° (12), we have investigated whether reduced 
temperature undermines the ability of cultured neurons to maintain normal resting 
membrane potential during glutamate exposure. Large decreases in Atli would have 
several deleterious effects, including a reduction of the voltage-dependent Mg2+ blockade 
of NMDA receptor ion channels with attendant passage of toxic quantities of Ca- into 
the neurons (13,14). 
3.2 Materials and Methods 
3.2.1 Materials. 
Tetraphenylphosphonium bromide (TPP+) was purchased from Acros Organics 
(Geel, Belgium). [3H]TPP+ (34 Ci/mmol), [14C]D-sorbitol (217 mCi/mmol) and [3H]H20 
(1 mCi/m1) were purchased from Dupont NEN (Boston, MA). All other chemicals were 
purchased from Sigma (St. Louis, MO). 67 
3.2.2 Uptake of [3H]TPP+ 
CGC cultures at 12 DIC were divided into two treatment groups: one was 
maintained throughout the experiment at 37° and the other at 22° C. The culture plates 
were washed three times with 1.0 ml Locke's buffer containing (in mM): 154 NaCl; 5.6 
KC1; 1 Mg Cl; 2.3 Ca Cl; 5.6 glucose; 8.6 HEPES; pH 7.4. To prevent depolarization­
induced cell volume changes from occurring, 100 mM sucrose was included in all 
buffers. The neurons were incubated for 5 min., after which the wash buffer was aspirated 
completely and replaced with 500 pl Locke's exposure buffer containing 5-10 .tM [3H] 
TPP+ (0.01  0.03 Ci/mmol). High K+ Locke's buffer containing 40mM NaC1 and 
120mM KCl was used to maximally depolarize neurons and determine AT-independent [ 
3I-IJTPP+ uptake. After a 60 min incubation during which the radiolabel was allowed to 
equilibrate between intra- and extracellular compartments, 5 pl of either L-glutamate (300 
p.M final concentration) or vehicle were added and the cells incubated for a period of 5 or 
20 min. The exposure buffer was then aspirated completely from the culture plates and 
analyzed for extracellular [3H]TPP+ content.  Intracellular [3H]TPP+ content was 
determined after solubilization of the neurons in 500 p.1 1% Triton X-100. All assays were 
performed in triplicate. 
3.2.3 Determination of Intracellular Space. 
Intracellular volume (ICV) was determined in both non-depolarized and K +­
depolarized neurons. Growth media was aspirated from the culture plates and the neurons 
washed three times in 22° C Locke's buffer containing 100 mM sucrose. The wash buffer 
was aspirated completely and replaced with 500 pl (4°C) Locke's containing [3H]f120 
and [14C]D-sorbitol. After gentle agitation for 1 min, 100 p.1 of the supernatant was 
removed and the volume of distribution of [3H]H20 (total intra- and extracellular space) 68 
and [14C]D-sorbitol (extracellular space)  determined. ICV was taken as the difference 
between total and extracellular spaces. 
3.2.4 Determination of AT. 
For each condition,  intracellular TPP+ concentration was calculated from 
intracellular volume and [3H]TPP+ determinations. The TPP+ distribution ratio (Rrpp+) 
was determined from the following equation: 
RTPP+ = ([1PP11".1C+ -[TP P+] hil(+)1[TP P+], 
RTpp+ was inserted into the Nernst equation to obtain AT as follows: 
RT 
AT =  log R
nF  TPP 
RT 
where  -61 at 37° and -58 at 22°
nF 
3.3 Results 
In the present study, 100 mM sucrose was present in all exposure buffers to 
prevent glutamate- and K+- induced neuronal swelling, which would otherwise confound 
the ability to determine [3H]TPP+ concentrations in CGCs. Under these hyperosmotic 
conditions, the intracellular volume was calculated to be 2.71 ± 0.13 gl/106 cells and 2.68 
± 0.84 gl/106 cells in low and high K+ media, respectively. 
As shown in figure 3.1, neuronal membrane potential did not change significantly 
when CGCs maintained at 37° were exposed to 300 !AM glutamate. AT  at 37° was 69 
Control  5 min  Ti 20 min 







Fig. 3.1 Change in the membrane potential of 12 DIC cerebellar granule neurons exposed 
to 300 tM glutamate in physiologic media. Neurons were incubated in the presence of 
[3H]TPP+ for one hr at the indicated temperatures before the addition of glutamate. 
Neurons and media were analyzed for [3H]TPP+ content at the indicated times after 
glutamate addition. Determination of membrane potentials was performed as described in 
Materials and Methods. Values represent the mean ± SEM from two experiments 
performed in triplicate. ** P < 0.003 
-65.6 ± 4.5 mV in control neurons, and -59.9 ± 5.2 and -57.3 ± 5.4 mV in glutamate-
exposed neurons after 5 and 20 min, respectively. In contrast, CGCs maintained at 22° 
were unable to sustain normal resting membrane potentials when exposed to 300 [IM 
glutamate. Although Atli in 22° control neurons (-64.1 ± 4.8 mV)  was not significantly 70 
different from controls at 37°, membrane potentials were reduced by 300 µM glutamate 
exposure to -57 ± 7.4 and -35.8 ± 6.3 mV after 5 and 20 min, respectively (fig. 3.1). 
3.4 Discussion 
The present results show that CGCs are able to maintain their membrane potentials close 
to resting levels when exposed to glutamate in physiologic media at 37°, but not when 
exposure occurs at 22°. These results are consonant with a previous report demonstrating 
that glutamate only induces excitotoxicity in rat CGCs in physiologic media when the 
temperature  is  reduced from 37° to 22° C (12). This inherent resistance of CGCs to 
acute glutamate-induced toxicity under physiologic conditions was thought to be due to 
their ability to maintain transmembrane electrochemical gradients at levels sufficient to 
preserve the voltage-dependent Mg2+ blockade of NMDA receptor ion channels. 
Excessive NMDA receptor activation would otherwise permit large amounts of Ca2+ and 
Na+ to enter the neurons, producing neuronal depolarization and Ca 2+ -mediated delayed 
neurotoxicity (15). Moreover, the ability to maintain resting membrane potential would 
limit the duration of glutamate exposures by preserving glutamate transport function, 
inasmuch as the glutamate transporter is driven by the co-transport of Na+ down its 
concentration gradient (16-18). Large reductions in the Na+ gradient can induce a 
reversed mode of glutamate transporter operation, thus increasing extracellular glutamate 
concentrations (17,18). Furthermore, maintenance of low intracellular Na+ concentrations 
would promote optimal functioning of the high capacity, low affinity Na + /Ca 2+ 
exchanger, the activation of which becomes critical for limiting intracellular Ca2+ 71 
concentrations during intense glutamate exposures (19-21).  Loss of  the  ability  to 
extrude intracellular Ca2+ would promote mitochondrial Ca2+ sequestration and toxicity, 
thereby reducing neuronal  energy levels (22). The current results therefore support the 
notion that reduced temperature facilitates the induction of glutamate neurotoxicity in 
CGCs by compromising their ability to maintain normal electrochemical gradients during 
glutamate-induced ion flux. 72 
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The participation of NMDA and non-NMDA receptors in domoic acid-induced 
neurotoxicity was investigated in cultured rat cerebellar granule cells (CGCs). Neurons 
were exposed to 300 1.1.M L-glutamate or 10 [tM domoate for two hours in physiologic 
buffer at 22° followed by a 22 hr incubation in 37° conditioned growth media. 
Excitotoxic injury was monitored as a function of time by measurement of lactate 
dehydrogenase (LDH) activity in both the exposure buffer and conditioned media. 
Glutamate and domoate evoked respectively, 50% and 65% of the total 24 hr increment in 
LDH efflux after 2 hrs. Hyperosmolar conditions prevented this early response, but did 
not significantly alter the extent of neuronal injury observed at 24 hrs. The competitive 
NMDA receptor antagonist, D(-)-2-amino-5-phosphonopentanoic acid (D-AP5), and the 
non-NMDA receptor antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline 
(NBQX), reduced glutamate-induced LDH efflux totals by 73% and 27%, respectively, 
whereas together, these glutamate receptor antagonists completely prevented neuronal 
injury. Domoate toxicity was reduced 65-77% when CGCs were treated with competitive 
and non-competitive NMDA receptor antagonists. Unlike the effect on glutamate toxicity, 
NBQX completely prevented domoate-mediated injury. HPLC analysis of the exposure 
buffer revealed that domoate stimulates the release of excitatory amino acids (EAAs) and 
adenosine from neurons. Domoate-stimulated EAA release occured almost exclusively 
through mechanisms related to cell swelling and reversal of the glutamate transporter. 
Thus, while glutamate-induced injury is mediated primarily through NMDA receptors, 
the full extent of neurodegeneration is produced by the coactivation of both NMDA and 
non-NMDA receptors. Domoate-induced neuronal injury is  also mediated primarily 
through NMDA receptors, which are  activated secondarily as  a consequence of 
AMPA/kainate receptor-mediated stimulation of EAA efflux. 76 
4.2 Introduction 
Among the excitatory amino acids (EAAs) known to produce toxic effects in the 
central nervous system, the neurotransmitter glutamate has been the most extensively 
characterized because of its  involvement in CNS pathologies such as  ischemia, 
hypoglycemia,  trauma  and  epilepsy  (1).  Physiologically,  rapid  glutamatergic 
neurotransmission is mediated by non-N-methyl-D-aspartate (non-NMDA) receptors 
(AMPA/kainate receptors), which are sodium-permeable ligand gated ion channels (2). 
Glutamate also interacts with NMDA receptors, which form calcium and sodium-
permeable ion channels that are activated in both a voltage and ligand dependent manner 
(3). NMDA receptors serve as coincidence detectors requiring concurrent depolarizing 
stimuli, such as occurs during high frequency synaptic activity, to relieve the voltage-
dependent Mg2+ block of the channel. In this context, NMDA receptor signaling 
produces incremental increases in cytoplasmic calcium which activates processes that are 
fundamental to long term changes in synaptic strength (4,5). In certain pathological 
conditions, however, neurons possess insufficient metabolic  energy to sustain normal 
resting transmembrane electrochemical gradients, and NMDA receptors  are excessively 
activated. This produces large sustained increases in cytoplasmic calcium that ultimately 
cause neurodegeneration (6-8). 
In dissociated hippocampal and cortical cultures, glutamate-mediated injury has 
been shown to progress through two distinct phases:  an early neuronal swelling that is 
dependent on extracellular sodium and appears to be mediated by AMPA/kainate 
receptors, and an NMDA receptor-mediated delayed neurodegeneration that is dependent 
on extracellular calcium (1). Naturally occuring excitotoxic compounds, such as kainate 
and domoic acid, are known to interact specifically with AMPA/kainate receptors yet 
induce a calcium-dependent CNS toxicity similar to glutamate (9,10).  The mechanisms 
by which AMPA/kainate receptor agonists cause neurotoxicity remain uncertain. In a 77 
number of vitro systems AMPA/kainate receptor-mediated neurotoxicity  is  largely 
dissociated from the involvement of NMDA receptors, since NMDA receptor antagonists 
fail to protect against non-NMDA receptor agonist challenge (11,12). Moreover, only a 
prolonged exposure to AMPA/kainate receptor agonists produces neuronal degeneration 
in some experimental systems (1.12), while acute exposures are sufficient to kill neurons 
in others (13-15). Thus, whereas the toxicity of glutamate can be clearly linked to NMDA 
receptor  activation  and  subsequent  calcium  entry,  the  mechanisms  underlying 
AMPA/kainate receptor-mediated, calcium-dependent neurodegeneration have not been 
well defined in cell culture systems. 
Studies in the adult animal show that AMPA/kainate receptor agonist-induced 
neurotoxicity  is mediated by both NMDA and non-NMDA receptors.  In the  rat 
systemically administered kainic acid produces siezures followed by necrosis of neurons 
in the hippocampus, amygdala, piriform cortex and other limbic  areas (16-18). Both 
competitive and non-competitive NMDA receptor antagonists have been shown to 
prevent the majority of this seizure related toxicity (16,17,19,20). These observations 
provide evidence consistent with the hypothesis that NMDA receptor activation plays  a 
central role in neurotoxicity resulting from activation of AMPA/kainate receptors. It is 
also apparent from studies documenting the neuroprotective effects of non-NMDA 
receptor antagonists in animal models of focal and global ischemia, that both classes of 
receptor play important roles in glutamate-induced neurotoxicity (21-27). 
In the present work, we have compared the mechanisms underlying glutamate-
and domoate-induced neurotoxicity in cultured rat cerebellar granule cells (CGCs). 
Domoic acid was chosen as a model AMPA/kainate  receptor agonist because it is a 
potential seafood contaminant with excitotoxic properties similar  to kainate (28). 
Glutamate was studied for comparison because of its well documented ability to induce 
NMDA receptor-mediated toxicity in a number of in vitro systems. CGCs are a useful 78 
system for this study because they express both NMDA and non-NMDA receptors (29) 
and can be grown in > 90% pure culture (30). 
An important consideration when using CGC's for toxicologic experimentation is 
that exposure conditions must be manipulated to overcome the inherent resistance CGCs 
have to the cytotoxic effects of excitatory amino acids (EAA) (6,7,31,32). Thus. the 
specific experimental conditions employed affect both the intensity and pathways by 
which EAA-induced neuronal damage occurs (1,33-35). For agonists such as domoate, an 
appropriate model should  utilize  a  physiologic medium, inasmuch  as  domoate 
intoxications are known to occur in initially healthy individuals (36,37). A physiologic 
medium preserves normal cell  signaling mechanisms by maintaining the voltage-
dependence of NMDA receptor activation and thus any functional interrelationships that 
exist between NMDA and AMPA/kainate receptors. 
In the present report, CGCs were exposed to glutamate and domoate in 
physiologic medium at a temperature of 22°. Reduced temperature conditions have 
previously been shown to increase the neurotoxic potency of glutamate in cultured 
neurons (13,38). This has allowed us to directly compare glutamate and domoate­
mediated toxicity under identical conditions and in the same temporal context (38). The 
present results confirm that glutamate and domoate toxicity are mediated by both NMDA 
and AMPA/kainate receptors. Moreover, we have shown in dissociated  neuron cultures 
that acute domoate-induced neurotoxicity is largely mediated through NMDA receptors, 
which are activated by endogenous EAAs released into the media. This domoate­
stimulated EAA efflux was pharmacologically characterized and shown  to occur by 
mechanisms other than the vesicular release of excitatory neurotransmitter stores. 79 
4.3 Materials and Methods 
4.3.1 Materials 
D(-)-2-amino-5-phosphonopentanoic  acid  (D-AP5),  L-trans-pyrrolidine-2,4­
dicarboxylic  acid  (PDA),  2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline 
(NBQX), and domoic acid were purchased from Tocris Cookson (Bristol, U.K). N6­
cyclopentyladenosine  (CPA),  8-(p-sulfophenyl)theophylline  (8-pSPT),  3-[(R)-2­
carboxypiperazin-4-yl]propy1-1-phosphonic  acid  (CPP),  N-(1- [2-thienyl] 
cyclohexyl)piperidine (TCP), (+)-5-methy1-10,11-dihydro-5H-dibenzo[a,d]cyclohepten­
5,10-imine maleate(MK-801), dextrorphan (DX) and dextromethorphan (DXM) were 
purchased from Research Biochemicals Inc. (Natick, MA). Tetrodotoxin (TTX) was 
purchased from Sankyo Co. LTD. (Tokyo). Acetonitrile, L-glutamate, glycine. N-methyl­
D-aspartic acid (NMDA), bovine serum albumin (BSA), trypsin, DNAse, poly-l-lysine 
(M.W. 393,000), cytosine arabinoside and o-phthaldialdehyde (OPT), soybean trypsin 
inhibitor (SBTI) were purchased from Sigma (St. Louis, MO). Basal Eagle's Medium 
(BME) was purchased from Gibco Labs (Grand Island, N.Y.). Chloracetaldehyde  was 
purchased from Fluka Chemicals (Switzerland). 
4.3.2 Cell Culture 
Primary cultures of cerebellar neurons were obtained from 8 day old Sprague 
Dawley rats as described by Novel li et. al. (6), with minor variations. In brief, cerebella 
were dissected and the cells dissociated and suspended in basal Eagle's medium 
supplemented with 25 mM KC1, 2mM glutamine, 10 % fetal calf serum, and 100 tg /m1 
gentamicin. Cells were seeded onto poly-l-lysine coated (5 Kg/m1) 6-well (35  mm dia.) 
culture dishes at a density of 2.5-3.5 x 105 cells/cm2. Care was taken to ensure a uniform 
plating density. The neurons were incubated at 37° in  a 5 % CO2, 95 % humidity SO 
atmosphere. Cytosine arabinoside (10 j.tM) was added after 18-24 hours to inhibit the 
replication of non-neuronal cells. At 8 days in culture, 100 1.1.1 of a 25 mg/ml D-glucose 
solution was added to each plate to replenish energy resources and compensate for 
evaporative losses (6). 
4.3.3 Excitotoxicity Assays 
Neurons were utilized for toxicological assays at 12 days in culture. Growth 
medium was collected and saved, and the neurons washed twice in  ml Locke's 1 
incubation buffer containing (in mM): 154 NaCI; 5.6 KCI; 1.0 MgC12; 2.3 Ca C12; 5.6 
glucose; 8.6 HEPES; 0.1 glycine; pH 7.4. For experiments in which a hyperosmolar 
medium was used to inhibit neuronal swelling, 100 mM sucrose was added. 1.0 ml of 
fresh Locke's buffer containing the various test compounds  was added to cultures 
followed by an incubation at 22° for 2 hrs. Control sister cultures were run in parallel 
with each treatment group. At the termination of incubation, the  exposure buffer was 
collected and saved for later analysis of lactate dehydrogenase (LDH) activity and the 
cultures washed twice in 1 ml fresh Locke's followed by replacement with 2.0 ml of the 
previously collected and saved growth medium which was supplemented with 2.5 mg/ml 
D-glucose. Neurons treated for 2 hrs in the presence of 100 mM sucrose were maintained 
with the same concentration of sucrose in the conditioned growth  medium. The cell 
cultures were returned to the 37° incubator. At 4, 8 and 24 hours after the beginning of 
the 2hr exposure, 0.25 ml aliquots of growth medium were collected and saved for 
analysis of LDH activity. LDH activity was assayed as described by Koh and Choi (39). 81 
4.3.4 Measurement of Excitatory Amino Acids and Adenosine Release 
Exposure conditions  in  release  studies  were  identical  to  those  used  in 
excitotoxicity assays. Exposure buffer was collected at various timepoints and assayed for 
excitatory amino acid (EAA) content by HPLC after precolumn derivitization with o­
phthaldialdehyde (OPT) (40). In general, 40 41 borate buffer (saturated solution, pH 9.5), 
20 p1 of an OPT solution (50 mg in 4.5 ml 100% methanol, 0.5 ml borate buffer, 50 111 
ethanethiol) and 100 tl 100% methanol were added to a 40 111 aliquot of exposure buffer. 
Twenty microliters of the derivatized sample was applied to the column 2 min after the 
addition of OPT. A reverse phase column (Supelco LC-18 250  x 4.5 mm i.d.) was 
employed with a guard column (15 x 4.6 mm i.d.), both packed with 5 1.tm dia. particles. 
The effluent was monitored fluorimetrically using  a model FS-970 Kratos fluorometer 
with the following settings for detection: excitation monochronometer 229 nm. a 470 nm 
cutoff filter for emission measurement, a 1.0 .tA full scale  range setting with a time 
constant of 0.5 s, and a sensitivity setting of 5.42 units. The mobile phase was 0.0125 M 
Na-,HPO4 (pH 7.2) and acetonitrile in a gradient from 9 to 17  percent over 8 minutes 
followed by an increase to 49 % over 2 min, a hold for 3 min, and reduction to 9 % over 2 
min to purge the column. Aspartate and glutamate were detected at retention times of 4.9 
and 6.9 minutes, respectively. 
Adenosine was measured fluorometrically after precolumn conversion to the N6­
etheno derivative (41). Equal volumes of chloracetaldehyde and  exposure buffer were 
mixed (0.675 % final chloracetaldehyde concentration) and placed in a boiling water bath 
for 20 min. After cooling, 20 ill of the extract was injected onto the column using the 
same HPLC apparatus as for EAA measurement but with  a 50 mM acetate (pH 4.5) and 
6.5 % acetonitrile mobile phase (2 ml/min). For adenosine  detection, the excitation 
monochronometer was set to 280 nm with a 418 nm emission cutoff filter, a 0.05 to 
range setting with 5 s time constant, and sensitivity setting of 5.80 units. 82 
4.4 Quantification of Results 
4.4.1 Excitotoxicity assays 
For each timepoint, total LDH activity in triplicate plates was calculated, the 
results averaged and LDH efflux in excess of control sister cultures run in parallel 
determined. The LDH efflux value obtained from exposure buffer at 2 hours was added to 
the 4, 8, and 24 hour growth medium LDH efflux values to give the total A LDH 
EI-PLUX, which is a measure of the cumulative change in LDH activity over time. 
Results were normalized to the 24 hour LDH activity induced by either 300 jiM L-
glutamate or 10 1.1M domoic acid. Nonlinear regrassion analysis and graphs were made 
using Graphpad Prism software (San Diego, CA.). 
4.4.2 Excitatory Amino Acid and Adenosine Efflux. 
The fluorescent detection of adenosine, glutamate and aspartate derivatives was 
recorded on a Linear model 585 chart recorder. Peaks were excised and weighed, and the 
quantity of extract determined by comparison with external standards. External standards 
were expressed as a measurement of the area under the peak in picomoles. The quantity 
of amino acids or adenosine in sample extracts were then converted into units of 
concentration in the exposure buffer. 
4.5 Results 
In a previous report, we demonstrated that a 2 hr exposure to 300 JIM L-glutamate 
or 101.1M domoate produced maximal neuronal losses of 65 and 79 %, respectively, in 12 
DIC cerebellar granule neurons in a physiologic buffer at 22° (38). Moreover, this level of 83 
EAA-induced neuronal injury was associated with a five- to eight-fold increase in lactate 
dehydrogenase (LDH) activity in the exposure buffer after two hours. Control neurons 
remained unaffected by these experimental manipulations. In the present experiments. 
identical exposure conditions were utilized and neuronal injury assessed by measuring 
LDH activity in the exposure buffer after 2 hrs and in conditioned growth media at 2. 4 
and 22 hrs after the termination of excitotoxin exposure. A 24 hr profile of progressive 
neuronal injury was therefore derived from this cumulative change in LDH activity. 
As shown in figure 4.1a, 50 ± 1.6 % of the 24 hr cumulative LDH efflux occured 
during the 2 hr glutamate exposure. Similarly, 64 ± 6.0 % of the domoate-stimulated 
LDH efflux was induced acutely (fig. 4.1b). Inasmuch as significant neuronal swelling 
was apparent within the first five minutes of EAA exposure, we investigated the extent to 
which osmotically driven swelling produced neuronal injury and LDH efflux. EAA-
induced neuronal swelling was inhibited completely when 100 mM sucrose was added to 
both the exposure buffer and conditioned growth media. Moreover, LDH efflux at the 2 
hr timepoint was reduced to 2.5 ± 0.8 % and 2.7 ± 0.7 % of 24 hr totals for glutamate and 
domoate, respectively. Therefore, the early leakage of LDH from neurons was generated 
by osmotic swelling (fig. 4.1a and 4.1b). After 24 hrs, however, there was  no significant 
difference in total LDH activity in media from neurons exposed to EAAs under 
hyperosmolar as compared to isosmolar conditions (fig. 4.1a and 4.1b). Neuronal damage, 
which comprised a loss of approximately 70 % of the neurons with the disappearance of 
the majority of neurites, was virtually identical at 24 hrs under control and hyperosmolar 
conditions. This finding suggested that swelling by itself did not directly induce neuronal 
injury, but instead unmasked early damage to membranes and/or cytoskeletal elements. 
Neurons exposed to sucrose alone for 24 hrs were unaffected by the hyperosmolar 
conditions. 84 
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Fig. 4.1 A LDH efflux from 12 DIC rat cerebellar granule neurons exposed to 300 tM L-
glutamate (a) or 10 1.1.M domoate (b). Neurons  were exposed to excitotoxins in  1 ml 
Locke's buffer for 2 hrs. At the termination of excitotoxin exposure, the Locke's buffer 
was replaced with 2 ml conditioned growth media supplemented with glucose and the 
neurons placed in the 37° / 5% CO2 incubator. Aliquots of growth media were collected 
at  the indicated times after excitotoxin  exposure and the units of LDH activity 
determined. Values represent LDH activity in  excess of non-intoxicated controls that 
were run in parallel with treated neurons. Slash marks indicate the change from exposure 
buffer to conditioned growth media. Each growth media LDH activity value was added to 
that determined from the exposure buffer to obtain a 24 hr profile of neuronal injury. 
Values are means ± SEM from at least 7 experiments run in triplicate. ** P < 0.001 as
compared to controls. 85 
In order to characterize NMDA and non-NMDA receptor contributions to 
glutamate- and domoate-induced cytotoxicity, the neuroprotective capacity of glutamate 
receptor antagonists was investigated. When glutamate receptor antagonists were utilized 
only during the 22 hr post-exposure period, no neuroprotection was afforded (results not 
shown). Moreover, EAA receptor antagonist neuroprotection  was not significantly 
different  between  neurons  treated  with EAA receptor  antagonists  during  the 
excitotoxicant exposure only or for the entire 24 hrs. Furthermore, cumulative 24 hr LDH 
activity was not significantly different between neurons treated in the presence or absence 
of 100 mM sucrose. Therefore, neurons were treated with glutamate receptor antagonists 
during EAA exposures only, and in the absence of sucrose. 
Figure 4.2a shows the 24 hr cumulative LDH efflux levels in media from neurons 
exposed 2 hrs to 300 pM glutamate. In the presence of 10 i.tM NBQX,  a concentration 
which would prevent the activation of AMPA and kainate receptors (24), glutamate-
induced cytotoxicity was reduced modestly to 73 ± 10 % of control. Moreover, neurons 
exposed to glutamate in the presence of NBQX appeared as swollen after 2 hrs as neurons 
exposed to glutamate alone. By 24 hrs. neurite thinning and membrane  blebbing were 
apparent and absolute neuron loss appeared somewhat reduced as compared  to control. 
The competitive NMDA receptor antagonist D-AP5 reduced  glutamate-induced LDH 
efflux more substantially, to 27 ± 3 % of control, and completely prevented neuronal 
swelling. Furthermore, little neuronal loss was apparent and neurites showed only minor 
thinning. When both EAA receptor antagonists were included in the exposure buffer, 
cerebellar granule neurons were afforded complete protection from  neurotoxic injury 
(LDH efflux = -0.4 ± 3.1 % of control). As depicted in fig. 4.2a,  NMDA was tested and 
found to produce only 21 ± 3 % of control glutamate cytotoxicity. 
The EAA receptor antagonist neuroprotection profile against  domate-exposed 
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4.2 Glutamate receptor antagonist neuroprotection profile in 12  DIC cerebellar granule 
neurons challenged with 3001AM L-glutamate (a) and 101.tM domoate (b). Bars represent 
the sum of the LDH activity, in excess of parallel-run controls, measured in the exposure 
buffer at 2 hrs and conditioned media at 24 hrs after initiation of glutamate exposure. 
Values are means ± SEM for at least 3 experiments  run in triplicate. ** P < 0.001 as 
compared to glutamate control. R7 
NBQX completely protected neurons from domoate-induced swelling and injury. 
Surprisingly, NMDA receptor antagonists also provided substantial neuroprotection 
against domoate-induced toxicity (figure 4.2b). The competitive NMDA receptor 
antagonists D-AP5 and CPP reduced domoate toxicity to 34 ± 3 and 23 ± 2 % of controls. 
respectively. Similarly, non-competitive NMDA receptor antagonists provided substantial 
neuroprotection. MK-801 reduced domoate toxicity to 25 ± 6 % of control, while 
dextrorphan, dextromethorphan and TCP reduced domoate-induced toxicity to 35 ± 4. 35 
± 5 and 26 ± 2 % of control LDH efflux, respectively. Although NMDA  receptor 
antagonists afforded substantial neuroprotection after a 2 hr domoate exposure. it was 
noted that neurons appeared swollen to the same degree  as glutamate control neurons yet 
underwent rapid recovery after replacement of the 37° conditioned growth media. By 24 
hrs, neurites showed evidence of membrane blebbing and appeared thinner while the 
somata were unaffected by domoate treatment in the presence of NMDA  receptor 
antagonists. 
These results suggest that the majority of domoate-induced neurotoxicity  is 
mediated by NMDA receptors, which may be activated  as a consequence of domoate­
stimulated release of endogenous EAAs. To test this hypothesis, cultures  were exposed 
to10 [IM domoate for 20 min and the incubation buffers assayed for  the presence of 
glutamate and aspartate. The resultant EAA concentrations in  exposure buffers from 
cultures containing approximately 2.5 x 106 neurons per plate were 10.0 ± 0.9 I.J.M and 5.3 
± 0.76 gIVI for glutamate and aspartate, respectively. Although  neuron densities were 
invariant between plates within a given culture, populations between cultures varied from 
2.5  3.5 x 106 neurons per plate; therefore, results of EAA  measurements were 
normalized to account for inter-experimental variability in amino  acid concentrations 
resulting from neuron density variations. Figure 4.3 shows  the concentrations of 
glutamate and aspartate in 1 ml of buffer after a 20 minute domoate exposure. NBQX 
completely prevented EAA efflux from  neurons exposed to domoate. The competitive 88 
NMDA receptor antagonist CPP reduced glutamate and aspartate efflux, respectively, to 
45 ± 7 % and 15 ± 1 % of glutamate control. Similarly, the non-competitive NMDA 
receptor antagonists MK-801, dextromethorphan and dextrorphan reduced domoate­
stimulated EAA efflux to 23 ± 8, 21 ± 3 and 29 % for glutamate and 9 ± 4, 15 ± 7 and 19 
% for aspartate, respectively. These findings indicate that domoate, through the activation 
of non-NMDA receptors, induces the release of glutamate and aspartate from cultured 
cerebellar granule neurons. Glutamate and aspartate in turn activate NMDA  receptors, 
which appear to promote further increases in EAA efflux into the exposure buffer. 
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Fig. 4.3 Efflux of L-glutamate and L-aspartate from 12 DIC cerebellar granule neurons 
exposed to 10 [IM domoate for 20 min. Neurons were exposed to domoate in 1 ml of 
Locke's buffer at 22° and aliquots analyzed for glutamate and aspartate by HPLC. Results 
were normalized to control L-glutamate concentrations. Values for all treatments except 
DX (N=1) represent means ± SEM from at  least  3 experiments. CPP. 3-(R-2­
carboxypiperazin-4-y1)-propy1-1-phosphonic  acid;  DXM,  dextromethorphan;  DX, 
dextrorphan; Mk-801, methyl -10,11-dihydro-5-H-dibenzocyclohepten-5,10-imine NBQX, 
2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline .* P < 0.005 89 
To characterize the mechanism(s) of domoate-stimulated EAA release. cerebellar 
granule neurons were exposed to 10 j.tM domoate in a 1.0 ml volume and the buffer 
assayed for glutamate and aspartate at specific timepoints during the 20 minute  exposure 
(figure 4.4). After a lag of 1  to 2 minutes, glutamate and aspartate concentrations 
increased  biphasically up to  the  15  minute timepoint,  after which time EAA 
concentrations plateaued. When neurons were pre-incubated for 1 hr with 200 .t.Y1 L­
trans-pyrrolidine-2,4 dicarboxylic acid (PDA), a competitive and transportable inhibitor 
of the high affinity glutamate transporter, glutamate and aspartate concentrations were 
reduced by 47 ± 10 and 55 ± 15 %, respectively, at the 15 minute timepoint. Glutamate 
and aspartate efflux were reduced even further, by 90 ± 4 and 94 ± 5 % respectively, 
when swelling of PDA pre-exposed neurons was prevented with 100 mM sucrose. In this 
case, the EAA efflux profile appeared monophasic. The presence of sucrose alone 
reduced domoate-stimulated glutamate and aspartate efflux by 61 ± 3 and 80 ± 1 %, 
respectively. 
From these results, it appears that domoate-exposed cultured cerebellar granule 
neurons release EAAs by two primary routes: reversal of the sodium-dependent glutamate 
transporter and via osmotically driven swelling with attendant EAA efflux. Further 
investigations were performed to ascertain whether  a vesicular component of EAA 
release was also  present.  Tetrodotoxin (TTX) was utilized  to  inhibit  neuronal 
depolarization resulting from Na+ influx through voltage-dependent  sodium channels. 
Neurons treated with 3 1.1M TTX showed  a slight but significant reduction in the rapid 
phase of domoate-induced EAA efflux, but without  a corresponding reduction in 
maximum EAA concentration (figure 4.5). When 10 1,1M CPA  was used to activate A1 
adenosine receptors. and thereby inhibit vesicular release of EAAs, no change in 90 
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Fig. 4.4 EAA efflux from 12  DIC  cerebellar granule neurons exposed to domoate. 
Cerebellar granule neurons were exposed to 10 1.tM domoate in a 1.0 ml volume and the 
buffer assayed for glutamate (a) and aspartate (b) at specific timepoints during the 20 
minute exposure. Results were normalized to the maximum control value attained during 
the domoate exposure. Values represent means ± SEM from at least 3 experiments. * P < 
0.05 ** P < 0.005 *** P < 0.001 91 
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Fig. 4.5 EAA efflux from 12 DIC cerebellar granule neurons exposed to 10 µM domoate. 
Neurons were exposed to domoate in  a 1.0 ml volume and the buffer assayed for 
glutamate (a) and aspartate (b) at specific timepoints during the 20 minute exposure. 
Results were normalized to the maximum control  value attained during the domoate 
exposure. Values represent means ± SEM from at least 3 experiments. * P < 0.05 ** P < 
0.005 *** P < 0.001 92 
domoate-induced EAA efflux  occured. The adenosine receptor  antagonist  8-(p­
sulphophenyl)theophylline (8- pSPT), however, elicited an increase in the rapid phase of 
domoate-induced glutamate efflux and elevated the maxumum glutamate concentration to 
136 ± 4 % of domoate-stimulated controls (figure 4.5a). This 8-pSPT-induced increase in 
glutamate efflux was completely prevented by 3 i_tM TTX. 8-pSPT, however, was without 
effect on aspartate efflux (figure 4.5b). These results suggest that a small vesicular 
component of domoate-stimulated glutamate release is prevented by tonic adenosine 
receptor activation. The exposure buffer was therefore examined for the presence of 
adenosine. As shown in figure 4.6, 10 p.M domoate caused the cerebellar granule  neurons 
to release adenosine monophasically into the buffer. In three separate experiments 
(approx. 2.5 x 106 neurons/plate) the adenosine concentration in exposure buffer at 20 
min reached a level of 1.25 ± 0.1 JIM (fig. 4.6). 
4.6 Discussion 
A primary aim of  this  study was  to  characterize domoic acid-induced 
neurotoxicity in cultured cerebellar granule neurons under experimental conditions which 
simulate the neuronal milieu present in human intoxications. Inasmuch  as the CNS 
pathology resulting from domoic acid intoxication occurs in normal healthy subjects, the 
model described herein employs a physiologic media which  preserves normal cell 
signaling mechanisms. In a previous report, glutamate excitotoxicity was characterized in 
CGCs under identical exposure conditions (38). The present study extends those previous 
findings and directly compares glutamate- and domoate-induced neurotoxic processe 
An initial concern was that the duration of excitotoxin exposure might induce an 
ion influx of sufficient magnitude to cause osmotic rupture of the neurons. Prevention of 
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Fig. 4.6 Adenosine efflux from 12 DIC cerebellar granule  neurons exposed to 10 !AM 
domoate. Neurons were exposed to domoate in a 1.0 ml volume and the buffer assayed 
for adenosine at specific timepoints during the 20 minute exposure. Results represent 
means ± SEM from 3 experiments. 
neurons. These findings are similar to those of Goldberg and Choi (8), who have shown 
that inhibition of swelling in cortical neuron cultures during oxygen-glucose deprivation 
protects against acute injury but not delayed neurodegeneration. In the present report, 
hyperosmotic conditions were expected to reduce total LDH accumulation by  an amount 
equivalent to that released directly by osmotic rupture; however, this was not the case. 
We suggest that swelling produces acute neuronal injury only when membrane  or 
cytoskeletal elements are damaged by processes related to NMDA receptor activation and 
Ca2+ entry into neurons. This conclusion is supported by the observation that neurons 
exposed to domoate in the presence of NMDA receptor antagonists appeared swollen  to 94 
the same extent as domoate-exposed controls after 2 hours, but recovered and were 
protected from subsequent neurodegeneration. 
The present results indicate that NMDA and non-NMDA receptors functionally 
interact to produce acute glutamate- and domoate-induced excitotoxic  responses, and 
both excitotoxins produce a primarily NMDA receptor-mediated cytotoxicity when 
exposed in a physiologic medium at 22°.  These results differ from those previously 
reported by Kato et al. (15), who investigated kainate toxicity in CGCs. In their  report. 
kainate-induced LDH release occurred within 30 minutes in 8 DIC and older CGCs, 
whereas glutamate was non-toxic at any age in culture. Moreover, neither acute nor 
delayed kainate toxicity appeared to involve the activation of NMDA receptors. There are 
several possible explanations which may account for these differences. First  and 
foremost, 100 p.M glycine was included in all exposure buffers in the present study. We 
have found that glycine enhances both the excitotoxic potency and efficacy of glutamate 
and augments NMDA-induced toxicity in this system (38). The inclusion  of glycine 
renders this CGC medium physiologic inasmuch  as glycine is present at micromolar 
levels in cerebrospinal fluid (41) and is required as a coagonist for NMDA receptor 
activation (42). The absence of glycine therefore will bias results  away from the 
involvement of NMDA receptors. Second, neurons were subjected to a longer excitotoxin 
exposure period in the present study than in the report of Kato, et al. A longer excitotoxin 
exposure in conjunction with conditions that permit NMDA receptor signaling  may 
explain why glutamate produced significant toxicity in this study. Third, kainate and 
domoate may not act in an identical manner to cause toxicity in CGCs. Domoate has been 
shown to induce larger currents through G1uR5 homomeric  receptors than kainate (43); 
therefore, differences in the ability to activate native AMPA/kainate  receptors are likely 
to  contribute  to  differences  observed  between  kainate- and  domoate-induced 
excitotoxicity. Moreover, the mechanisms of kainate- and domoate-induced EAA release 
from synaptosomes appear to be distinct (44). The  presence of glycine in the exposure 95 
buffer and distinct patterns of EAA release are therefore the most parsimonius 
explanations for the differences in the results with domoate, reported herein, and the 
previously described effect of kainate in CGCs (15). 
Pharmacologic studies have shown that NMDA receptor-mediated increases in 
intracellular Ca2+ concentration are a major cause of excitatory amino acid-induced injury 
and death in neurons (1). Non-NMDA receptors, however, can also produce increases in 
intracellular Ca2+ by depolarizing neuronal membranes and activating voltage operated 
Ca2+ channels (45). AMPA/kainate receptor-mediated accumulation of intracellular Na+ 
may also allow Ca2+ entry through the Na+/Ca2+ exchanger, which can operate in a 
reverse mode when the cell is depolarized (46). These mechanisms may account for the 
mild injury to CGCs induced by glutamate and domoate when NMDA receptor activation 
is blocked. Recent reports have also demonstrated the  presence of Ca2+-permeable 
AMPA/kainate receptors in specific neuronal and glial populations within the CNS: 
however, their existence on cerebellar granule neurons has not been reported (47). 
AMPA/kainate receptor-mediated depolarization may also increase free cytoplasmic Ca2+ 
by facilitating release of the Mg2+ blockade of NMDA receptor ion channels. This 
mechanism would explain why the AMPA/kainate receptor antagonist, NBQX, reduced 
the  neurotoxic  efficacy of glutamate  in  this  study.  Moreover,  the  absence of 
AMPA/kainate receptor involvement would partially account for the relatively mild 
injury incurred by CGCs during NMDA exposure. The lower efficacy of NMDA,  as 
compared to glutamate in the presence of NBQX, may be explained by the partial agonist 
profile of NMDA at NMDA receptors (48,49). 
An interesting finding was that domoate excitotoxicity is mediated predominantly 
by NMDA receptors under the conditions employed. This finding is in  agreement with 
those of Favaron, et al. (13) and Manev, et al. (14), who demonstrated  that kainate 
toxicity in CGCs could be reduced significantly by non-competitive  NMDA receptor 
antagonists. Moreover, these findings agree with in vivo studies demonstrating that brain 96 
damage induced subsequent to kainic acid-induced seizures is mediated by NMDA 
receptors (16-19). Novel li et al. (12) demonstrated that domoate-containing toxic mussels 
produce neurotoxicity in neuronal cultures through a synergism between excitatory amino 
acids. Their data show that subtoxic concentrations of domoic acid potentiate the 
excitotoxic effect of glutamate and aspartate, and that this neurotoxic synergism may 
occur through a reduction of the Mg2+ block at the NMDA receptor ion channel. Our data 
confirm and extend this earlier study by showing that the direct non-NMDA receptor-
mediated effect of domoate produces only mild injury after a 2 hour exposure, whereas 
severe excitotoxicity results from the  ability of domoate. through AMPA/kainate 
receptors, to stimulate the release of endogenous EAAs and effect a NMDA receptor-
mediated neurotoxicity. 
Competitive and non-competitive NMDA receptor antagonists reduced domoate­
stimulated EAA release by 55 to 80 percent (fig. 3). Therefore. NMDA receptors mediate 
not only the majority of domoate-induced neuronal injury, but also a major component of 
EAA efflux. Kiedrowski et al., (50), demonstrated in cultured cerebellar granule  neurons 
that transient applications of glutamate cause NMDA receptor-mediated increases in 
intracellular Na+ that often exceed 60 mM. These large reductions in the Na+ gradient 
were shown to impair the ability of neurons to extrude and/or buffer cytoplasmic Ca2+, 
presumably due to a decrease in the efficiency of the Na+/Ca2+ exchanger (50,51).  We 
propose that, in addition to compromising the Nal-/Ca2+ exchanger, large NMDA 
receptor-mediated reductions in the Na+ gradient inhibit or reverse the operation of the 
Na+-dependent glutamate transporter. This possibility was investigated pharmacologically 
using PDA, a transportable, competitive inhibitor of the Na+-dependent  glutamate 
transporter (52). Indeed, when the reversed mode of glutamate transporter operation  was 
inhibited by preloading neurons with PDA (53), domoate-stimulated  glutamate and 
aspartate efflux were reduced by 50% (fig. 4). The remainder of non-vesicular  EAA 
release evoked by domoate was almost completely accounted for by mechanisms related 97 
to cell swelling. Neurons and astrocytes have been shown to counteract hyposmolarity­
induced increases in cell volume by releasing taurine (54-58). Moreover, these regulatory 
volume decreases appear to involve chloride channels (59,60) with a molecular size 
exclusion limit of approximately the size of glutamine (61). Glutamate and aspartate are 
also released in response to cell swelling, and by a mechnism that has been shown to be 
inhibited by hyperosmotic sucrose (55). Sucrose alone in the present experiments 
prevented 61 and 80 percent of domoate-induced glutamate and aspartate release. 
respectively. The combination of sucrose and PDA reduced glutamate and aspartate 
efflux by 90 and 94 percent, respectively, indicating that domoate-stimulated EAA 
release occurs almost exclusively through mechanisms related to cell swelling and 
reversal of glutamate transport (fig. 4). 
In a number of reports,  the neuronal release of glutamate resulting from 
depolarization or ischemia has been shown to occur by two primary mechanisms: Cat+­
dependent vesicular release (62) or, in pathological conditions, by reversal of the high 
affinity Nat-coupled glutamate transporter (53,62). The extent to which either mechanism 
predominates depends upon factors that affect neuronal energetics and ion homeostasis 
(62,63). Thus, experiments in cerebellar granule neurons show that the majority of EAA 
release induced by elevated K+ or veratridine originates from vesicular pools (64-66), 
whereas ischemia-induced EAA release has variably been shown to arise from vesicular 
(67), non-vesicular (68,69) or both vesicular and non-vesicular pools (70,71).  In the 
present study little  if any of the domoate-stimulated EAA accumulations could be 
accounted for by exocytotic mechanisms. Instead, we found that vesicular release of 
EAAs was inhibited by the concurrent release of endogenous adenosine from the neurons 
(fig. 6). Thus, a tonic inhibition of exocytotic EAA release was revealed by the adenosine 
receptor antagonist 8-pSPT (fig. 5a). 8-pSPT potentiated domoate-induced glutamate 
release in a TTX-sensitive manner, whereas aspartate accumulations were unaffected by 
this adenosine receptor antagonist (fig. 5b). This finding  suggests that aspartate is not 98 
contained in synaptic vesicles, a notion that is supported by a number of other in vitro 
studies (for review, see 72), including those on synaptosomes (63,73) and CGCs (74). 
The demonstration that exocytotic glutamate release is inhibited by endogenous 
adenosine during domoate exposure is compatible with the results of Heron and Seylaz 
(75), who monitored the effects of veratradine and ischemia on intrahippocampal amino 
acid concentrations in rats by microdialysis. Under ischemic conditions. adenosine 
receptor agonists failed to modify EAA release, whereas theophylline significantly 
potentiated glutamate efflux, thus, indicating the presence of tonic adenosine receptor 
activation. Conversely, during veratridine-induced depolarization, adenosine receptor 
agonists reduced EAA release while theophylline was without effect. Thus, under the 
present conditions, cerebellar granule neurons appear to respond to domoate in a manner 
similar to ischemic neurons in vivo. Moreover, the present results are consonant with data 
showing that, not only is adenosine released in response to stimulation by NMDA and 
non-NMDA receptor agonists (76,77), but adenosine and its analogues also inhibit EAA 
release in a manner that is reversed by adenosine A1 receptor antagonists (78.-80). 
Recently, Tasker et al. (81), demonstrated that the competitive NMDA receptor 
antagonist CPP significantly attenuates CNS neurotoxicity when administered prior to 
domoate in rats, whereas MK-801 alone produced deleterious effects and AP5  was 
marginally protective. It was suggested that the failure to demonstrate a convinving 
neuroprotective response to AP5 is related to the poor bioavailability of this compound. 
In accordance with this interpretation our results with the direct application of NMDA 
receptor  antagonists  in  vitro  demonstrated  an  attenuation  of domoate-induced 
neurotoxicity. Certainly, more detailed investigations will be required to ascertain the 
effectiveness of NMDA receptor antagonists against domoate neurotoxicity in vivo. 
In conclusion, this report demonstrates that cultured cerebellar granule neurons in 
a physiologic milieu respond to NMDA and non-NMDA receptor agonists in a manner 
consistent with that reported in vivo. We have shown that the acute excitotoxic response 99 
to both glutamate and domoate is predominantly mediated by NMDA receptors. NMDA 
receptors have been shown to be expressed in CGCs in primary culture (82). Glutamate 
activates NMDA receptors directly to produce a neurotoxic response. Concurrent non-
NMDA receptor activation by glutamate produces an additional depolarizing stimulus 
which  in  turn  potentiates  excitotoxicity,  either by increasing  intracellular Ca2+ 
concentrations through voltage-sensitive Ca2+ channels, modulation of the Na +ICa2+ 
exchanger, or by reduction of the voltage-dependent Mg2+ blockade of NMDA receptor 
ion  channels.  In  contrast,  domoic  acid  produces  a NMDA receptor-mediated 
excitotoxicity  indirectly  through  the AMPA/kainate receptor-activated  release  of 
glutamate and aspartate into the medium. Domoate, therefore, synergistically potentiates 
glutamate/aspartate-mediated neurotoxicity. Cultured cerebellar granule  neurons also 
respond to domoate-induced depolarization by releasing adenosine, which acts  to 
suppress exocytotic release of glutamate; however, this compensatory response is offset 
by severe alterations in ion gradients which cause non-vesicular EAA release through 
both a reversal of high affinity glutamate transport and osmotically driven mechanisms. 100 
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5.1 Abstract 
The conditions required for growth and survival of cerebellar granule neurons in 
vitro are known to alter the developmental regulation of NMDA receptor subunit mRNA. 
In  the  present  report, we have examined the  functional  and  pharmacological 
characteristics of NMDA receptors on cerebellar granule neurons at 12 days in culture (12 
DIC). Under open-channel conditions in extensively washed membranes, [31-1]MK-801 
labeled a uniform population of sites (Kd = 3.2 ± 0.3 nM) in a saturable manner (Bmax = 
416 ± 18 fmol/mg); however, biexponential association and dissociation kinetics 
indicated the possible existence of at least two NMDA receptor populations which differ 
in pharmacological properties. The kinetically derived equilibrium dissociation constants 
for the high and low affinity binding components were 0.56 and 771 nM, respectively. 
The equilibrium competition analysis of MK-801 and other channel blocking compounds 
as displacers of [3H]MK -801 revealed the presence of high and low affinity binding sites 
with relative apportionments of 70% and 30% respectively. The rank order potency 
profile of competitor binding at the high affinity site was (+)-MK-801  > TCP > 
dextrorphan > dextromethorphan > (+)-ketamine. When tested for the ability to protect 12 
DIC  cerebellar  granule  neurons  from  acute  glutamate-induced  toxicity.  the 
neuroprotective rank order potency of these compounds was MK-801 > TCP > 
dextrorphan > (+)-ketamine > dextromethorphan, which correlated significantly with the 
high affinity competition binding profile and thus established the role of NMDA 
receptors in glutamate toxicity. The findings of these experiments indicate that NMDA 
receptors on 12 DIC cerebellar granule neurons are a heterogenous population that 
functionally mediate glutamate-induced neurotoxicity. The heterogenous [3H]MK -801 
binding sites may represent NMDA receptor channels composed of different subunits. 110 
5.2 Introduction 
Glutamate is believed to be the primary excitatory neurotransmitter in the 
mammalian central nervous system. It produces its actions through ionotropic NMDA, 
AMPA and kainate receptor subtypes and G-protein coupled metabotropic receptors, with 
each receptor subtype having a characteristic pharmacological profile and distinct 
physiological properties (1,2). Unique among ionotropic glutamate receptors is the 
NMDA receptor because of its high ca++ permeability and involvement in synaptic 
plasticity,  long term potentiation,  learning and memory, and neurodegeneration. 
Regulation of NMDA receptor activity  is complex. In addition to the binding of 
glutamate, NMDA receptor activation requires the binding of glycine at a distinct 
strychnine-insensitive coagonist site (3-6). The NMDA receptor ion channel is blocked in 
a voltage-dependent fashion by Mg++, thus a concurrent depolarizing stimulus is required 
for the passage of ions to occur (7,8). In addition, pharmacologically distinct modulatory 
sites exist for the binding of Zn++ (9) and polyamines (10-12). 
NMDA receptors have been characterized pharmacologically using a variety of 
compounds, among which are the dissociative anesthetics phencyclidine (PCP) and 
ketamine. The most potent of these channel blocking agents is the prototypical drug 
dizocilpine maleate (MK-801). These and related compounds are non-competitive 
NMDA receptor antagonists which act by binding to sites within the NMDA receptor ion 
channel in a voltage- and use-dependent manner. Their utilization in electrophysiologic 
and radioligand binding studies has revealed that NMDA receptor pharmacology is 
regionally heterogeneous within the CNS (13-17). The basis for this pharmacological 
heterogeneity has recently been confirmed by cloning studies showing that the NMDA 
receptor is composed of two distinct types of subunit encoded by five separate genes, one 
termed NMDAR1 (NR1) and four others termed NMDAR2A to NMDAR2D (NR2A-D) 
(18-20). Eight isoforms of NR1 cDNA generated by alternative mRNA splicing have also been identified (9,21-23). NR1 is capable of assembling as a homooligomer that 
possesses many of the properties of the NMDA receptor. NR2 subunits however, do not 
form functional receptors but instead potentiate NMDA receptor activity when in 
heteromeric assembly with NR1. NR2 subunits also confer a functional variability to 
NMDA receptor channel complexes  that  is  dependent upon  specific NR1-NR2 
heteromeric combinations (20.24). Because the NR1 subunit is essential to the formation 
of functional NMDA receptors. it  is expressed in virtually all neurons of the CNS, 
whereas NR2 subunits display distinct heterogenous expression patterns (19,25). 
NMDA receptor diversity is especially evident in the cerebellum, where studies 
have shown [3H]MK-801 binding to be of lower affinity than in other brain areas (26-28). 
Earlier reports revealed either no detectable binding of [314]1\4K-801 to adult rat cerebellar 
membrane homogenates (29.30), or low levels of [3H]MK -801 binding in extensively 
washed membranes (27). A unique cerebellar NMDA receptor pharmacology has also 
been demonstrated with the channel blocking compounds [3H]dextrorphan (16) and [3H] 
TCP (14,31). It is now known that cerebellar granule neurons are unique in that they 
express high levels of the NR2C subunit, thus contributing to the distinct pharmacology 
of cerebellar NMDA receptor channels and distinguishing cerebellar NMDA receptors 
from those in forebrain regions, which contain an abundance of NR1. NR2A and NR2B 
subunits but no NR2C expression (18-20,25). 
Cerebellar granule neurons have been used extensively  for  studying  the 
neurophysiology and neurotoxicology of glutamate receptors. In vitro growth and survival 
of cerebellar granule neurons requires the presence of high KC1 concentrations or NMDA 
treatment. Prolonged K+ depolarization specifically upregulates the expression of NR2A 
mRNA through an increase in resting intracellular calcium concentration (32,33). In 
addition, these treatments permit developmental changes in NR2B and NR2C mRNA 
expression that  are normally observed during in vivo cerebellar granule neuron 
development, namely the disappearance of NR2B and increase in NR2C mRNAs (33,34). 112 
The precise NR2 subunit stoichiometry of NMDA receptors in cultured cerebellar 
neurons is however uncertain and appears to vary with age in culture. Thus, agents acting 
on NMDA receptors may display a changing pharmacology as a function of age of 
cerebellar granule neurons in vitro. 
In  light of these recent findings,  it  is  noteworthy that channel blocking 
radioligands have not been utilized in a rigorous examination of the pharmacology 
NMDA receptors in cultured cerebellar granule neurons. Such a characterization may 
provide further insight into the pharmacologic and functional characteristics of the 
endogenous cerebellar NMDA receptor phenotype. To address this issue, we have used 
[3H]MK -801 to investigate the pharmacology of NMDA receptors in membranes derived 
from cerebellar granule neurons at 12 days in culture. Cerebellar neurons at this age have 
been shown to maximally express NMDA receptors and to be most sensitive to 
glutamate-induced toxicity (35). We have also assessed the potency of MK-801 and 
several other channel blocking agents to exert neuroprotective action against a maximally 
toxic glutamate challenge in cerebellar granule neurons. 
5.3 Materials and Methods 
5.3.1 Materials 
L-glutamate, glycine, trypsin, cytosine arabinoside and fluorescein diacetate were 
purchased from Sigma (St. Louis, MO). N-(1- [2-thienyl]cyclohexyl)piperidine (TCP), 
(+)-5-methy1-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801), 
dextrorphan (DX), dextromethorphan (DXM) and (+)-ketamine  were purchased from 
Research Biochemicals Inc. (Natick, MA). Ethidium bromide was obtained from Bio Rad 
(Hercules, CA), and ( +)- [3H]MK -801 was purchased from New England  Nuclear 113 
(Boston, MA). Basal Eagle's medium was purchased from Gibco Labs (Grand Island. 
N.Y.). 
5.3.2 Cerebellar Granule Cell Culture 
Primary cultures of cerebellar granule neurons were obtained from 8 day old 
Sprague Dawley rats by a previously described method (36). Briefly, isolated cerebella 
were stripped of their meninges and minced by mild trituration with a Pasteur pipette. 
Cerebella were then treated with 2200 U/ml trypsin (Sigma cat. no. T-8918) for 15 min. 
at 37°C, and the granule cells dissociated by two successive trituration and sedimentation 
steps. Cells were suspended in Dulbecco's basal Eagle's medium containing 10% fetal 
bovine serum, 2 mM glutamine, 25 mM KC1 and 100 lg/m1 gentamicin, and plated onto 
poly-l-lysine (M.W. = 393,000) coated polystyrene culture dishes at a density of 2.5 x 105 
cells/cm2. Care was taken to ensure a uniform neuron distribution by thorough mixing of 
the suspension after addition to each plate. For excitotoxicity assays, neurons were plated 
onto 6-well 35 mm culture dishes (Fisher) whereas cells harvested for [3H]MK -801 
binding assays were plated onto single 100 mm plates. Cells were incubated at 37°C in a 
5% CO-), 95% humidity atmosphere. Cytosine arabinoside (10 11.M) was added 18-24 hrs 
later to inhibit replication of non-neuronal cells. At 8 days in culture, 50 tL/ml of a 25 
mg/ml D-glucose solution was added to replenish energy resources and to compensate for 
growth media evaporative losses. 
5.3.3 Excitotoxicity Assays 
Cerebellar granule neurons were exposed to L-glutamate and non-competitive 
NMDA receptor antagonists at 12 days in culture at a temperature of 22°C. Prior to 
glutamate exposure, growth medium was removed and the cultures exposed for 5 minutes 114 
to 1 ml Locke's incubation buffer containing (in mM): 154 NaCI; 5.6 KC1; 1 Mg Cl; 2.3 
CaCI; 5.6 glucose; 0.1 glycine; 8.6 HEPES; pH 7.4. The buffer was then replaced with 1 
ml of fresh Locke's containing 300 tM L-glutamate with or without NMDA  receptor 
antagonists and the cultures incubated for 2 hrs. Glutamate exposure was terminated by 
washing the neurons three times in fresh Locke's solution. The  neurons were then 
maintained for a one hour post-exposure incubation in fresh Locke's prior  to a five minute 
staining with the vital dye fluorescein diacetate (5µg /ml). Ethidium bromide (10 p.1 of a 
50 pl/m1 solution) was added four minutes after the fluorescein diacetate  to stain the 
nuclei of nonviable neurons. The dye solution was replaced with fresh Locke's and the 
neurons placed on an  inverted microscope  (Zeiss model 1M35) equipped with 
fluorescence optics. Soma and neurites of live neurons  appear bright green in color 
whereas dead neurons do not accumulate fluorescein. Nuclei of dead neurons, that are not 
washed away, appear red due to ethidium bromide staining. 
5.3.4 Assessment of Neuronal Viability 
Five to six randomly selected fields from each plate  were photographed at 80X 
magnification. Live neurons were counted from the photographic slides and the results 
averaged for each concentration of noncompetitive NMDA receptor antagonist. Results 
were referenced to the average control culture populations processed in parallel  to 
experimental plates. 
5.3.5 Preparation of Cerebellar Granule Cell Membranes 
Membranes were prepared from neurons at 12 days in culture. Growth media was 
replaced with 2 ml of cold (4°C) 5 mM HEPES buffer (pH  7.4) containing 10 mM 
EDTA, the neurons scraped and collected in  a 40 ml Dounce, homogenized, and then 115 
centrifuged 10 minutes at 18000 rpm. The supernatant  was discarded and the pellet 
resuspended with 20 ml HEPES/EDTA and recentrifuged. This last step was repeated in 5 
mM HEPES without EDTA and the pellet was frozen for at least 30 min  at -70° C. 
Membrane pellets could be stored frozen for up to one month with  no loss in binding 
sites. Pellets were then thawed for 30 min, resuspended in 20 ml HEPES without EDTA. 
and centrifuged. This final pellet was resuspended in an appropriate volume of 5 mM 
HEPES for use in radioligand binding assays. Membrane protein content was determined 
by the method of Lowry (37). 
5.3.6 Radioligand Binding 
[3H]MK -801 binding was determined in a reaction mixture containing 75-100 1..tg 
of cerebellar granule cell membrane protein, 10 1.04 glutamate,  10 1.tM glycine, H10 or 
competitor and 10 1.1.M EDTA in 5 mM HEPES pH 7.4 at 22°C, for a final volume of 1 
ml. Non-specific binding is defined as that occurring in the presence of 10 1.1M (+)-MK­
801. Under these conditions at 22°C, the (+)-PHJMK-801 association reaction progresses 
to >97% completion by 5 hr. After an incubation of 5 hr at 22°C, the reaction  was 
terminated by rapid filtration over Whatman GF/B glass fiber fliters in a Brandel M48-R 
cell harvester. Filter strips were presoaked in 0.5% polyetheleneimine  for a minimum of 2 
hr to reduce binding of ligand to the filters. Filter discs were allowed to elute for at least 9 
hr in Cytoscint liquid scintillation cocktail and then counted  on a Beckman LS 6000SC 
scintillation counter. 
5.3.7 Data Analysis 
Nonlinear regression analysis was performed with Graphpad  Inplot software (San 
Diego, CA). EC50 values for neuroprotection against exposure to glutamate and [I-I]MK­116 
801 competition binding to membranes were determined by nonlinear least squares fitting 
of a logistic equation to concentration response data. These data were analyzed according 
to the following equation: 
(B  A)
Y = A + 
1+(C/[X])49 
where Y equals the response, C is the ED50, [X] the antagonist concentration. D the slope 
factor and A and B the minimum and maximum plateaus of the concentration-response 
curve. Saturation isotherms were similarly parameterized through non-linear regression 
analysis-based fitting of a hyperbolic equation to the data. 
The parameters of [31-1]MK-801  association and dissociation kinetics were 
determined by fitting the following exponential equations: 
RB t =1[RBetil E- e 
1=1 
RBI =I[RBo] e 
t=1 
where, for site  i of n total sites, RBt is the amount of bound radioligand at time  t. RBeq is 
the amount of radioligand bound at equilibrium, 'cob, is the  apparent association rate 
constant, RBo is the amount of bound radioligand at t = 0, and k_1 is the dissociation rate 
constant. 
The criterion for assigning a multiple site model to equilibrium and kinetic ligand 
binding analyses is the F statistic: 
(SS 1 SS 2)1 (df  df 2) F = 
(SS 21 df 
where SSI and SS2 are the sum of squares of the residuals for the one-and two-site fits. 
respectively, and dfi and df2 are the degrees of freedom for one- and two-site fits. 117 
5.4 Results 
Non-competitive NMDA receptor antagonist binding is known to be selectively 
stimulated by the NMDA receptor coagonists L-glutamate and glycine in extensively 
washed, divalent cation depleted rat brain membranes under low ionic strength conditions 
(30,38). Initial experiments revealed that concentrations of 100p.M glutamate and glycine 
were required to maximally stimulate [3H]MK -801 binding. When such conditions were 
utilized in equilibrium binding studies using membrane preparations from 12 DIC 
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Fig. 5.1 Saturation analysis of 0.1-10 nM (3H)MK-801 binding to extensively washed 12 
DIC cerebellar granule neuron membranes. Membranes were incubated for 5 hrs at 22° in 
the presence of 1001.tM L-glutamate and glycine. Scatchard plot (inset) of the data yielded 
a Kd of 3.2 ± 0.3 nM and a Bmax of 416 ± 18 fmol/mg protein in this preparation. Data is 
from one of three similar experiments. 
(Fig. 5.1). Using 101.IM unlabeled MK-801  to define non-specific binding, specific 
binding accounted for > 60% of the total binding at a [31-1JMK-801 concentration of 1.5 
nM. Nonlinear regression analysis of the saturation data averaged from three experiments 118 
indicated the presence of a uniform population of sites with apparent affinity (Kd) and site 
density (Bmax) values of 3.2 ± 0.3 nM and 416 ± 18 fmol/mg protein, respectively (Fig. 
5.1). The inset depicts the linear Scatchard replot of these data. 
The association of [3H]MK -801 with its recognition site on 12 DIC cerebellar 
granule cell membranes, in the presence of 10011M L-glutamate and glycine at 22° and at 
a radioligand concentration of 1.5 nM, progressed with a t05  of 41.5 minutes (Fig. 5.2). 
Equilibrium was not attained under these conditions until after 300 min.,  at which time 
binding was > 97% complete. Non-linear regression analysis of the kinetics of association 
of [3H]MK -801 indicated, however, that a simple bimolecular reaction model could not 
adequately account for the observed binding data. The fit was significantly improved by 
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Fig. 5.2 Association kinetics of (3H)MK -80l binding  to extensively washed 12 DIC 
cerebellar granule cell membranes. Binding  was initiated at 22° by addition of 1.5 nM 
(3H)MK-801 to membrane preparations at specific time intervals in the presence of 100 
M L-glutamate and glycine. Termination of the binding  reaction was achieved by 
simultaneous filtration using a Brandel 48-well cell  harvester as described in Materials 
and Methods. Normalized binding values  represent the average of three experiments. 
Error bars were removed for clarity, but were no greater than 10% SEM. Inset: Kobs vs 
(3H)MK-801 concentration for  the fast and slow components of radioligand  binding.
Plots are from a single experiment using (3H)MK-801  concentrations of 2.5, 5.0 and 7.5 
nM. 119 
acceptance of a more complex biexponential binding model (F = 70.6, p < 0.0001) which 
resolved [31-I]MK-801 binding into two kinetic components (kobsi = 88.2 ± 12 x 10-3 min-' 
and kobs, = 10.1 ± 0.44 x 10-3 min-1), with 35% of the total in the fast phase (t112 = 8 min) 
and 65% in the slow (tu, = 69 min). The kinetics of [3H]MK -801 dissociation (Fig. 5.3), 
initiated by addition of 101N MK-801, was similarly described by a more complex 
biexponential binding model (F = 97.5, p < 0.0001), while the t0.5 for the overall 
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Fig. 5.3 Dissociation kinetics of (3H)MK-801 binding to 12 DIC cerebellar granule cell 
membranes. After incubation of 1.5 nM (3H)MK-801 with membranes for 5-6 hrs  at 22° 
and in the presence of 100 IN L-glutamate and glycine. 10 tM MK-801  was added at 
specific time intervals and the binding terminated by rapid filtration. Normalized binding 
values represent the average of three experiments. SEM for each time point  was no 
greater than 10%. 
dissociation process was 54.2 min. The dissociation  rate constants for the two 
components derived from non-linear regression analysis were: Li,  = 83.3 ± 13 x 10-' 
min-1 and k_12 = 4.25 ± 0.48 x 10-3 min-1, with 45% of the total in the fast  phase (t112 = 8 
min) and 55% in the slow (t11, = 172 min). 120 
Association (1c1) constants for the fast and slow components of [3H]MK -801 
binding were ascertained by determining the kobs values for the fast and slow components 
of binding as a function of [3H]MK -801 concentration. The kinetics of both components 
of [311]MK-801 association followed a pseudo-first order pattern as demonstrated by the 
kobs values varying linearly as a function of ligand concentration (Fig. 5.2 insets). The 
rate constants (k+1) derived from this kinetic analysis were respectively 7.53 ± 0.25 x 106 
M-1 min-1 and 0.108 ± 0.013 x 106 M-1 min-1 for the fast and slow components. The 
ratios of dissociation and association rate constants, k_1/k+1, were used to calculate 
dissociation constants (KD) for high and low affinity binding sites. The resultant 
kinetically derived KD values for PI-INK-801 were 0.56 and 771 nM. 
NMDA receptor pharmacology was examined further by ascertaining the affinity 
of MK-801 and other channel blocking compounds as displacers of [3H]MK -801 from 12 
DIC cerebellar granule cell membranes. For all compounds except ketamine. competition 
TABLE 5.1 
Neuroprotective potencies in live neurons and competition potencies for (31-1)MK-801 
binding in membranes prepared from 12 DIC cerebellar granule  cells.  In  vitro 
neuroprotection and (3H)MK-801 binding assays were performed  as described in 
Materials and Methods. Data were fit to a logistic equation by nonlinear regression 
analysis using Graphpad Inplot software as described in Materials and Methods. 
Compound  Neuroprotective 
EC50 (nM) 
Competition 
High affinity (nM) % 
Binding IC50 
Low affinity (.tM) 9­
95% CI 
(high) 
MK-801  8.28  (8.0-9.0)  3.3  73  4.18  27 
TCP  165  (115-236)  14.9  73  38.3  27  10-22 
Dextrorphan  1427  (1260-1620)  147  71  313  29  111-194 
Ketamine  7022  (4400-11000)  1074  100  820­
1400 
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Fig. 5.4 (3H)MK-801 competition binding in 12 DIC cerebellar granule cell membranes. 
Assay was performed as described in Materials and Methods, using washed membranes 
in the presence of 100 1,tM glycine and L-glutamate. Values for each point  are the means 
± SEM of data from at least three experiments. Non-specific binding was defined by 10 
M MK-801. 
curves were best described by a two site model (p < 0.0001), with 69-73% of the total 
being high affinity sites (Fig. 5.4 and Table 5.1). The rank order potency profile of 
competitor binding at the high affinity site was (+)-MK-801 (IC50H = 3.3 nM) > TCP 
(IC50H = 14.9 nM) > dextrorphan (IC50H = 147 nM) > dextromethorphan (IC50H = 402 
nM) > (+)-ketamine (IC50 = 1074 nM). For the low affinity site, the rank order of 
potency was (+)-MK-801 (IC50L = 4.18 [tM) > dextromethorphanrphan (IC50L = 26.8 p. 
M) > TCP (IC50L = 38.311M) > dextrorphan (IC50L = 313 liM). 
In order to determine the relative potencies of noncompetitive antagonists  as 
neuroprotectants, these compounds were tested for their ability to block glutamate-
induced neurotoxicity in cerebellar granule cells. In the absence of  non-competitive 122 
antagonists, viable neurons were reduced by 65% when exposed for 2 hrs to 3001..tM L-
glutamate in physiological buffer at 22° C (data not shown). As shown in figure 5.5, 
NMDA receptor noncompetitive antagonists potently and completely protected against 
glutamate-induced toxicity with a rank order potency profile of (+)-MK-801 (EC50 = 8.28 
nM) > TCP (EC50 = 165 nM) > dextrorphan (EC50 = 1.43 1.1M) > (+)-ketamine (EC50 = 
7.02 p.M) > dextromethorphan (EC50 = 14.8 p.M). This rank order potency profile was 
significantly correlated with the affinities of these compounds for the high affinity 
[3H]MK -801 binding sites (Fig. 5.6; r = 0.96, p = 0.008). 
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Fig. 5.5 Concentration response curves for non-competitive NMDA receptor antagonist 
neuroprotection of cerebellar granule neurons at 12 days in culture. Neuron cultures were 
exposed to 300 1.tM L-glutamate for 2 hr at 22° in the  presence of 100 p.M glycine. 
Quantitation of the neurotoxic response was performed as described in Materials and 
Methods. Results represent the average ± SEM of at least three separate experiments. 123 
5.5 Discussion 
A requirement for the growth and survival of cerebellar granule neurons in vitro is 
the presence of depolarizing conditions, which are thought to mimic the influence of tonic 
physiological activation in immature neurons during cerebellar development (39.40). An 
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Fig. 5.6 Correlation between the potencies of compounds to compete for high affinity 
(3H)MK-801 binding in  12 DIC cerebellar granule neuron membranes and their 
neuroprotective potencies against a 300 1..tM L-glutamate challenge (r = 0.96, p = 0.008). 
The significance of the correlation was evaluated by two-tailed t test of the probability 
that r = 0. 
ensembles and signal transduction elements. These preparations afford the opportunity to 
explore the pharmacologic properties of cells expressing distinct heteromeric forms of 
NMDA receptors.  It  has been shown that depolarizing conditions induce the up-
regulation of NR2A subunit mRNA and down-regulate NR2B mRNA followed by  a 
gradual upregulation of NR2C subunit mRNA in cerebellar granule cells (32-34). These 124 
changes in NMDA receptor subunit mRNA expression in cultured cerebellar granule cells 
parallels in vivo granule cell maturation. which is associated with down-regulation of 
NR2B and upregulation of NR2A and NR2C expression (41-43). In cerebellar granule 
cell cultures at 12-14 days in vitro the levels of NR2A and NR2C are comparable. 
whereas NR2B is undetectable (34). One maturational trend which is not preserved in 
culture is the developmental increase in the ratio of the NR1b splice variant compared 
with NR1a, which lacks an N-terminal insertion encoded by exon 5. Thus, in cerebellar 
granule cell  cultures grown in depolarizing conditions the NR  subunit mRNA 
predominates, whereas in vivo the adult cerebellum displays a ratio of NR1b/NR1a of 
approximately 5:1 (34). In the present report we investigated the pharmacologic and 
toxicologic significance of the NMDA receptor subunit composition of 12 day in culture 
cerebellar granule neurons. 
The  affinities  of NMDA receptor  ligands  for  heterologously  expressed 
recombinant homomeric and heteromeric NMDA receptors have been measured and 
compared to those found in situ in rodent brain. Heteromeric NMDA receptors consisting 
of NR1-NR2A or NR1-NR2B have been shown to have [3H]MK -801 affinities that  are 
consonant with those found in native forebrain membranes (24,44-46). The [3H]MK -801 
binding affinity observed in the present study (Kd = 3.2 nM) suggests that NMDA 
receptors labelled by this radioligand in membranes derived from 12 DIC cerebellar 
granule neurons resemble that of assemblies of NR1 and either NR2A or NR2B subunits. 
Thus, the reported absence of NR2B mRNA in 12 DIC cerebellar granule cells suggests 
that the observed high-affinity binding of [3H]MK -801 represents the labeling of NR1­
NR2A complexes. This KD value for [3HJMK-801 is consonant with the values (4.0-7.3 
nM) reported for the labeling of NMDA receptors in membranes prepared from 10 day in 
culture  murine  cerebellar  granule  cells  (35).  The  affinity  of [3H]MK -801  for 
heterologously expressed heteromeric NR1-NR2C receptors has been demonstrated to be 125 
substantially lower than that measured in adult murine cerebellum, which expresses high 
levels of NR2C subunit mRNA (24,44). 
Recent studies using heterologously expressed NMDA receptor subunits suggest 
that NMDA receptor assemblies may be composed of three rather than two subunit types 
(44,45). Thus, Chazot, et.  al. (1994) found that transfection of HEK 293 cells with 
varying ratios of NR1, NR2A and NR2C DNA resulted in expressed  receptors that 
displayed an affinity for [3H]MK -801 which was identical to that measured in membranes 
from mouse cerebellum, but four-fold lower than that in mouse forebrain. Interestingly. 
when the level of transfected NR2A DNA was increased relative to NR2C, the resultant 
affinity for [3H]MK -801 tended to increase (lower KD values)  as well. Thus. the 
characteristic affinity of [3H]MK -801 for mature granule cell NMDA  receptors most 
closely parallels that of recombinantly expressed NMDA receptors containing NR1 and 
NR2A (and NR2C) subunits (44). It may therefore be inferred that the observed [3H]MK­
801 binding affinity on 12 DIC cerebellar granule cell membranes is due to an interaction 
with NMDA receptors containing primarily NR1-NR2A subunits with lesser amounts of 
NR2C. The use of a maximal [3H]MK -801 concentration of 10 nM in these equilibrium 
saturation studies precluded labeling of the lower affinity [3H]MK -801 binding  sites 
associated with either NR1-NR2A-NR2C or NRI-NR2C assemblies. 
Membranes from 12 DIC cerebellar granule neurons were further distinguished by 
the  apparent biexponential  kinetics  of [3H]MK -801  association and dissociation. 
Biexponential association and dissociation kinetics have similarly been  reported for [3H] 
MK-801 (47), [3H]dextrorphan (16) and [3H]TCP (48,49) binding to membranes derived 
from cerebral cortex and hippocampus. Although speculative, the  most parsimonious 
interpretation of the biexponential kinetics of [3H]MK -801 binding is that this represents 
binding to distinct NMDA receptor complexes with differing affinities. Consonant with 
this interpretation, the ratios of dissociation and association  rate constants yielded 
kinetically derived KD values of 0.56 and 771 nM which are in reasonable agreement 126 
with the affinities of [3H]MK -801 for recombinant NMDA receptors composed of NR1­
NR2A and NR1-NR2C, respectively (44). 
The notion that a heterogenous population of NMDA receptor channels exists on 
developing cerebellar granule neurons is further supported by the electrophysiologic 
studies of Farrant, et al. (50), who recorded single channel currents on cerebellar neurons 
during the period of migration from the external germinal layer to the inner granular layer 
of the cerebellum in rats from postnatal days 7 through 14. NMDA receptors  on 
premigratory and early postmigratory neurons were shown to possess high conductance 
channels whereas low conductance channels appear at  later postnatal stages and 
eventually predominate with age. These low conductance channels are characterized by 
much shorter (< 1 ms) mean open times and burst lengths than the higher conductance 
channels, which is a characteristic shared by recombinant NMDA receptor channels 
consisting  of  NR1-NR2C  heteromers  (51).  Moreover,  the  electrophysiologic 
characteristics of the high conductance channels measured in premigratory cerebellar 
granule neurons (50) are similar to those reported for cloned NMDA receptors consisting 
of NR1-NR2A or NR1-NR2B subunits (51). These findings have been extended by 
Ebralidze, et al. (52), who compared NMDA receptor channel conductances in cerebellar 
granule neurons from wild type mice and from mutant mice carrying  a deletion of the 
gene encoding the NR2C subunit. In the mutants, spontaneous channel openings in 
whole-cell recordings and NMDA-activated single-channel currents from outside-out 
patches revealed the presence of an exclusively large conductance channel. In contrast, 
wild type mice possesed NMDA receptors with  a wide range of single-channel 
conductances, which strikingly implies that individual channels in vivo  are made up of 
different combinations of all three subunits. Thus, rather than two distinct populations of 
channels made up of only two subunit types (eg NR1-NR2A or NR1-NR2C), NMDA 
receptors in mature granule cells appear to exist as multimeric complexes with varying 
stoichiomeric ratios of NR2A and NR2C subunits in combination with NR 1 (52). The 127 
existence of NMDA receptor channels  in  cerebellar granule cells  with differing 
proportions of NR2A and NR2C is consistent with the observed complexities of [3H]MK­
801 binding in the present study. 
In equilibrium competition experiments, [3H]MK -801 binding was displaced by a 
variety of non-competitive NMDA receptor antagonists. The rank order potency profile of 
these competitors was in general agreement with descriptions of the competitive 
displacement of [3H]MK -801 in human (26) and  rat (15,27,28,53) cerebral cortex and 
cerebellum. Moreover, these affinities for [31-I]MK-801 binding sites are well correlated 
with anticonvulsant potencies measured in rat (54) and mouse (55) experimental seizure 
models, and with the in vitro neuroprotection assay described in this report. The 
equlibrium competition binding data was best described by an interaction with both high 
and low affinity sites. The inability to adequately describe competition data with a one-
site model has similarly been described for [31-1]MK-801 binding sites in human frontal 
cortex (56), [3H]TCP sites in rat brain homogenates (38), and for [3H]clextrorphan sites in 
rat forebrain and cerebellar membranes (16). All three radioligands label NMDA receptor 
channels, and the heterogeniety of the [3H]MK -801 binding sites in membranes derived 
from 12 DIC cerebellar granule cells is again consistent with the existence of NMDA 
receptor channels with distinct assemblies of NR2 subunit forms. 
Regarding the relationship between multiple [3H]MK -801  affinity sites and 
neuroprotection, the non-competitive NMDA receptor antagonist rank order potency 
profile for neuroprotection reported here was highly correlated with the rank order profile 
for competition at high affinity [3H]MK -801 binding sites. These high affinity sites 
comprised approximately 70% of total displaceable [3H]MK -801 binding. These data 
suggest that the preponderance of NMDA receptor channels in 12 DIC cerebellar granule 
cells  are composed of NR1-NR2A complexes and these  channels mediate  the 
neuroprotective effects of noncompetitive antagonists. The NR1-NR2A NMDA receptor 
channels in cerebellar granule cells are responsible for the large-amplitude conductances 128 
and longer open time (40-52) properties and appear to mediate the neurotoxic effects of 
glutamate in these neurons. In contrast to NR1-NR2A channels, NMDA receptor 
channels composed of NR1-NR2C subunits display smaller-conductance levels and 
shorter open time (51). These channels are also less sensitive to Mg2+ and more sensitive 
to glycine than NR2A-containing complexes and therefore may be more likely to pass 
current in a given physiological situation (52). 
In conclusion, the observed characteristics of [3H]MK -801 binding provide 
pharmacological evidence that NMDA receptors on 12 DIC cerebellar granule neuron 
membranes are composed of at least two populations of channels with distinct subunit 
composition. One population of native NMDA receptor channels appears to be composed 
of NR1-NR2A subunits which constitute the high affinity binding site for [I-I]MK-801 
and the target for the neuroprotective actions of MK-801 and related non-competitive 
antagonists of the NMDA receptor. These data also suggest that glutamate induced 
excitotoxicity in 12 DIC cerebellar granule cells is related to the activation of NR1-NR2A 
heteromeric NMDA receptor channels. 129 
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